Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
RHO GTPase cycle	2.35E01	1.73E-01	8.832	ABL2,ADD3,AKAP13,ARAP2,ARHGAP18,ARHGAP26,ARHGAP29,ARHGAP31,ARHGAP32,ARHGAP6,ARHGEF11,ARHGEF12,ARHGEF3,BCR,CDC42BPA,CDC42BPB,CHN2,CUL3,DAAM1,DLC1,DOCK1,DOCK4,DOCK6,DOCK9,ERBIN,FAM135A,FARP1,FGD5,FILIP1,FMNL2,FRS2,GIT2,GJA1,HNRNPC,ITSN2,KALRN,KIDINS220,MCF2L,MPP7,MSI2,MTR,MYO6,MYO9A,NCKAP1,OPHN1,PDE5A,PHIP,PICALM,PIK3CA,PIK3R1,PIK3R3,PKN1,PKP4,PLEKHG1,PREX2,RALGAPA1,RAPGEF1,RASAL2,RHOBTB1,RHOJ,ROCK1,ROCK2,SH3RF1,SLK,SOS1,SOS2,SPATA13,SPEN,SPTAN1,SPTBN1,SRGAP1,SRGAP2,STARD13,TIAM1,TJP2,TRIO,USP9X,WIPF1	
PTEN Signaling	1.32E01	2.19E-01	-4.914	AKT3,BCL2,BCL2L1,BMPR2,CBL,CCND1,CNKSR3,FGFR2,FLT1,FLT4,FOXO1,FOXO3,GHR,IGF1R,INPP5F,INSR,ITGA1,ITGA6,KDR,MAGI1,MAGI3,MAST2,NFKB1,PIK3CA,PIK3R1,PIK3R3,PREX2,PTK2,RPS6KB1,SOS1,SOS2,TGFBR2,TGFBR3	
Chronic Myeloid Leukemia Signaling	1.27E01	1.62E-01	5.814	ABCB1,ABL1,AKT3,BCL2,BCL2L1,CCND1,CRKL,FOXO3,FZD6,GAB2,HDAC4,HDAC7,HDAC8,HDAC9,JAK2,LEF1,MECOM,MSI2,NFAT5,NFKB1,NOTCH1,NUMB,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,RB1,RBL2,RPTOR,SMAD3,SOS1,SOS2,SPRED1,STAT3,TCF4,TCF7L2,TGFB2,TGFBR2,USP7,XIAP	
Cardiac Hypertrophy Signaling (Enhanced)	1.26E01	1.24E-01	7.070	ACVR2A,ADCY9,AKAP13,AKT3,ATF2,ATF6,BMPR2,CACNA1E,Diaph2,DLG1,FGF13,FGFR2,FZD6,GHR,GNAQ,HDAC4,HDAC7,HDAC8,HDAC9,IGF1R,INPP5F,ITGA1,ITGA6,ITPR1,ITPR2,JAK2,MAP2K5,MAP2K6,MAP3K1,MAP3K2,MAP3K20,MAP3K3,MAPK8,MEF2A,MEF2C,NFAT5,NFKB1,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PKN1,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,PTK2,ROCK1,ROCK2,RPS6KB1,STAT3,TGFB2,TGFBR2,TGFBR3	
Myelination Signaling Pathway	1.19E01	1.47E-01	4.041	ACVR2A,AKT3,APC,ARHGAP6,ATF2,BMPR2,BRAF,CHD8,CREBBP,DLC1,FGFR2,FZD6,HDAC4,HDAC7,HDAC8,HDAC9,IGF1R,ITGA6,LAMA4,LAMC1,NFKB1,NOTCH1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PRKACB,PTK2,PTPRA,RAPGEF2,ROCK1,ROCK2,RPS6KB1,RPTOR,SLC16A1,SMAD1,SMAD3,SMAD5,SMAD6,SMARCA4,SOS1,SOS2,TCF4,TCF7L2	
Hepatic Fibrosis Signaling Pathway	1.18E01	1.32E-01	5.940	ACVR2A,AKT3,APC,ATF2,BCL2,BMPR2,BRAF,CACNA1E,CCND1,CREBBP,CSNK1G1,FLT1,FLT4,FOXO1,FZD6,ITGA1,ITGA6,JAK1,JAK2,KDR,LEF1,LEPR,LRP5,MAP2K5,MAP2K6,MAPK8,NFKB1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KB1,SMAD3,SOS1,SOS2,SP1,STAT3,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3,TRPM7	
HGF Signaling	1.17E01	2.2E-01	5.000	AKT3,ATF2,CCND1,CRKL,DOCK1,ELF2,ETS1,GAB1,ITGA1,ITGA6,MAP3K1,MAP3K2,MAP3K3,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RAPGEF1,SOS1,SOS2,STAT3	
Protein Kinase A Signaling	1.13E01	1.31E-01	2.832	ADCY9,ADD3,AKAP10,AKAP11,AKAP13,AKAP7,ATF2,BRAF,CREBBP,DUSP3,EYA3,FLNB,GNAQ,ITPR1,ITPR2,LEF1,MAP3K1,MTMR3,MYH10,NFAT5,NFKB1,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PHKB,PLCB1,PLCB4,PLCG1,PPP1R12A,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,PTPN14,PTPN4,PTPRA,PTPRB,PTPRG,PTPRK,PTPRM,ROCK1,ROCK2,SMAD3,TCF4,TCF7L2,TGFB2,TGFBR2	
Gap Junction Signaling	1.03E01	1.38E-01	1.938	ADCY9,AKT3,ATF2,CCND1,CREBBP,CSNK1G1,DLG1,GJA1,GNAQ,ITPR1,ITPR2,LEF1,LRP5,MAP2K5,MAP3K2,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,PTPRM,SMAD1,SMAD3,SMAD5,SMARCC2,SOS1,SOS2,SP1,TCF4,TCF7L2,TJP1,TJP2	
Role of NFAT in Cardiac Hypertrophy	1.02E01	1.61E-01	5.112	ADCY9,AKT3,CACNA1E,GNAQ,HDAC4,HDAC7,HDAC8,HDAC9,IGF1R,ITPR1,ITPR2,MAP2K6,MAP3K1,MAPK8,MEF2A,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RCAN2,SOS1,SOS2,TGFB2,TGFBR2	
Adipogenesis pathway	9.68E00	1.94E-01	-0.577	ACVR2A,BMPR2,CLOCK,DGKD,EBF1,FBXW7,FGFR2,FOXO1,FZD6,HDAC4,HDAC7,HDAC8,HDAC9,KAT2B,KAT6A,Kat6b,MNAT1,NR1D1,PPIP5K1,RB1,RPS6KB1,RPS6KC1,SAP130,SMAD1,SMAD3,SMAD5,TBL1XR1	
IL-3 Signaling	9.48E00	2.53E-01	4.025	AKT3,CRKL,FOXO1,GAB2,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RAPGEF1,SOS1,STAT3	
Factors Promoting Cardiogenesis in Vertebrates	9.39E00	1.83E-01	4.811	ACVR2A,APC,ATF2,BMPR2,CCND1,CREBBP,FZD6,LEF1,LRP5,MAPK8,MEF2C,PLCB1,PLCB4,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,ROCK1,ROCK2,SMAD1,SMAD5,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3	
Role of Tissue Factor in Cancer	9.3E00	1.59E-01	5.048	ACVR2A,AKT3,BCL2,BCL2L1,BMPR2,BRAF,FLT1,FLT4,GNAQ,ITGA6,JAK2,KDR,MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,Ppp2r5c,PPP2R5E,PTK2,RB1,RBL2,RPS6KA3,RPS6KB1,RPS6KC1,TGFB2,TGFBR2,TGFBR3,ZEB1	
Pulmonary Fibrosis Idiopathic Signaling Pathway	9.19E00	1.32E-01	5.642	ACVR2A,AKT3,ATF2,BCL2,BMPR2,BRAF,CCND1,COL4A2,CREBBP,CXCL12,FGFR2,FOXO1,FOXO3,FZD6,JAK2,JARID2,LEF1,MAP2K6,MAPK8,NFKB1,NOTCH1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKN,PTK2,ROCK1,ROCK2,RPS6KA3,RPS6KB1,RPS6KC1,SMAD3,SOS1,SOS2,STAT3,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3,WWTR1	
Oxytocin Signaling Pathway	8.99E00	1.38E-01	5.284	AKT3,ATF2,CACNA1E,CREBBP,GJA1,GNAQ,ITPR1,ITPR2,MAP2K5,MAPK8,MEF2C,MPRIP,MYH10,MYH9,MYO10,MYO18A,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,ROCK1,ROCK2,SMARCC2,SOS1,SOS2	
Estrogen Receptor Signaling	8.92E00	1.2E-01	5.286	ADCY9,AKT3,ATF2,BCL2,CACNA1E,CCND1,CREBBP,FOXO1,FOXO3,GNAQ,IGF1R,JAK1,JAK2,LEPR,MCU,MED13,MED13L,MED14,MPRIP,NCOA1,NCOA2,NCOR1,NFKB1,NOTCH1,NRF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKDC,RBFOX2,ROCK1,ROCK2,RPS6KB1,SOS1,SOS2,SP1,TBL1XR1	
Renin-Angiotensin Signaling	8.88E00	1.98E-01	4.690	ADCY9,ATF2,GNAQ,ITPR1,ITPR2,JAK2,MAP3K1,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,SOS1,SOS2,STAT3	
FGF Signaling	8.77E00	2.33E-01	4.472	AKT3,ATF2,CREBBP,CRKL,FGF13,FGFR2,FRS2,GAB1,ITPR1,MAP2K6,MAP3K1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS1,SOS2,STAT3	
Regulation of the Epithelial-Mesenchymal Transition Pathway	8.74E00	1.59E-01	NaN	AKT3,APC,BRAF,ETS1,FGF13,FGFR2,FRS2,FZD6,GAB1,JAK1,JAK2,LEF1,MAP2K5,MAP2K6,NFKB1,NOTCH1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD3,SMURF1,SOS1,SOS2,STAT3,TCF4,TCF7L2,TGFB2,TGFBR2,ZEB1	
Growth Hormone Signaling	8.6E00	2.54E-01	3.638	GHR,IGF1R,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KA3,RPS6KB1,RPS6KC1,SOCS7,STAT3	
WNK Renal Signaling Pathway	8.58E00	2.08E-01	2.828	AKT3,CBL,CUL3,INSR,KLHL3,LRRC8C,LRRC8D,NR3C2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKN,SLC12A6,UBR1,WNK1,XIAP	
Pancreatic Adenocarcinoma Signaling	8.5E00	1.9E-01	3.873	ABL1,AKT3,BCL2,BCL2L1,CCND1,HDAC4,HDAC7,HDAC8,HDAC9,JAK1,JAK2,MAPK8,NFKB1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1,RBL2,SMAD3,STAT3,TGFB2,TGFBR2	
Integrin Signaling	8.43E00	1.51E-01	4.707	ABL1,AKT3,ARHGAP26,ASAP1,BCAR3,BRAF,CRKL,DOCK1,ITGA1,ITGA6,LIMS1,MAPK8,MPRIP,NEDD9,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCG1,PPP1R12A,Ppp1r12b,PTK2,RAPGEF1,RHOBTB1,RHOJ,ROCK1,SOS1,SOS2,TNK2,TSPAN5,WIPF1	
Human Embryonic Stem Cell Pluripotency	8.42E00	1.54E-01	4.849	ACVR2A,AKT3,APC,BMPR2,BRAF,FGFR2,FOXO1,FZD6,JAK1,JAK2,MAP2K5,MAP2K6,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SMAD1,SMAD3,SMAD5,SMAD6,SOS1,SOS2,STAT3,TGFB2,TGFBR2	
Cholecystokinin/Gastrin-mediated Signaling	8.31E00	1.93E-01	4.690	ATF2,GNAQ,ITPR1,ITPR2,MAP2K5,MAP2K6,MAPK8,MEF2A,MEF2C,PLCB1,PLCB4,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,SOS1,SOS2	
Senescence Pathway	8.26E00	1.3E-01	4.964	ACVR2A,AKT3,ASXL2,BMPR2,BRAF,CACNA1E,CCND1,CREBBP,ELF2,EP400,ETS1,FOXO3,HIPK2,ITPR2,ITSN2,KAT2B,MAP2K5,MAP2K6,MCU,NF1,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PPP3CA,PPP3CC,RB1,RBL2,SMAD1,SMAD3,SMAD5,SMAD6,TGFB2,TGFBR2,TGFBR3	
Ribonucleotide Reductase Signaling Pathway	8.26E00	1.64E-01	4.158	AKT3,ARID1A,ARID2,ATF2,BCL2,BRAF,BTRC,CCND1,CREBBP,FOXO3,MAPK8,NFKB1,PARP14,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1,RPTOR,SETD2,SMARCA2,SMARCA4,SMARCC2,SP1,STAT3,TNKS,TNKS2	
Netrin Signaling	8.14E00	1.62E-01	4.914	ABLIM1,AKT3,CACNA1E,DOCK1,ITPR1,ITPR2,MAPK8,NEO1,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,PTK2,TIAM1,TRIO,VTI1A	
Glioma Signaling	7.88E00	1.84E-01	3.873	ABL1,AKT3,CCND1,HDAC4,HDAC7,HDAC8,HDAC9,IGF1R,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RB1,RBL2,SOS1,SOS2	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	7.71E00	1.51E-01	5.292	AKT3,BRAF,ETS1,FGF13,FGFR2,FOXO1,FRS2,GAB1,JAK1,JAK2,MAP2K5,MAP2K6,MAP3K1,MAPK8,NFKB1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD3,SMURF1,SOS1,SOS2,STAT3,TGFB2,TGFBR2,WWTR1,ZEB1	
VEGF Signaling	7.65E00	2.02E-01	3.638	AKT3,ARNT,BCL2,BCL2L1,FLT1,FLT4,FOXO1,FOXO3,KDR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PTK2,ROCK1,ROCK2,SOS1,SOS2	
EGF Signaling	7.63E00	2.68E-01	3.873	AKT3,ITPR1,ITPR2,JAK1,MAP3K1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,RPS6KB1,SOS1,SOS2,STAT3	
Semaphorin Neuronal Repulsive Signaling Pathway	7.6E00	1.67E-01	-0.200	AKT3,ARHGEF12,FARP1,ITGA1,ITGA6,MAP2K5,MAP2K6,MPRIP,NRP1,PDE4B,Pde4d,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PLXNA2,PPP1R12A,Ppp1r12b,PRKACB,PRKG1,ROCK1,ROCK2,SEMA6A,SEMA6D	
NGF Signaling	7.54E00	1.83E-01	4.472	AKT3,ATF2,CREBBP,GAB1,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,ROCK1,ROCK2,RPS6KA3,RPS6KB1,RPS6KC1,SOS1,SOS2,TRIO	
Pancreatic Secretion Signaling Pathway	7.34E00	1.34E-01	5.396	ADCY9,AKT3,ARHGEF11,ARHGEF12,ARHGEF3,GNAQ,ITPR1,ITPR2,LIPA,MCU,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RASGRP3,ROCK1,ROCK2,RPS6KB1,RPTOR,STXBP5,STXBP6,VTI1A,WNK1	
Non-Small Cell Lung Cancer Signaling	7.3E00	2.02E-01	2.887	ABL1,AKT3,CCND1,FOXO3,HDAC4,HDAC7,HDAC8,HDAC9,ITPR1,ITPR2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,RB1,RBL2,SOS1,SOS2	
Mouse Embryonic Stem Cell Pluripotency	7.27E00	1.92E-01	4.025	AKT3,APC,BMPR2,CREBBP,FZD6,JAK1,JAK2,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD5,SOS1,SOS2,STAT3,TCF4,TCF7L2,XIAP	
Prostate Cancer Signaling	7.26E00	1.84E-01	NaN	ABL1,AKT3,ATF2,BCL2,CCND1,CREBBP,FOXO1,HDAC4,HDAC7,HDAC8,HDAC9,LEF1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1,RBL2,SOS1,SOS2	
Thrombin Signaling	7.24E00	1.38E-01	4.707	ADCY9,AKT3,ARHGEF11,ARHGEF12,ARHGEF3,GNAQ,ITPR1,ITPR2,MPRIP,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KB1,SOS1	
CXCR4 Signaling	7.2E00	1.55E-01	4.379	ADCY9,AKT3,ARHGEF11,CXCL12,DOCK1,ELMO1,GNAQ,ITPR1,ITPR2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2	
Tight Junction Signaling	7.16E00	1.5E-01	NaN	AFDN,AKT3,CASK,CNKSR3,CPSF6,CSTF3,EPB41,IGSF5,MARK2,MPDZ,MYH10,MYH9,MYO10,MYO18A,NFKB1,PARD3,PPM1L,PPP2R5E,PRKACB,SMURF1,SPTAN1,TGFB2,TGFBR2,TIAM1,TJP1,TJP2,VTI1A	
Epithelial Adherens Junction Signaling	7.14E00	1.58E-01	-0.200	ACVR2A,AFDN,AKT3,BMPR2,CTNND1,FER,IGF1R,LEF1,MAGI1,MYH10,NF2,NOTCH1,PPM1L,PPP2R5E,RAPGEF1,ROCK1,ROCK2,STK3,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3,TIAM1,TNS1	
PDGF Signaling	7.12E00	2.07E-01	4.243	ABL1,ABL2,CRKL,INPP5F,JAK1,JAK2,MAP3K1,MAPK8,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,SOS1,SOS2,STAT3	
Signaling by NOTCH1	7.11E00	2.18E-01	4.123	CREBBP,DLL4,FBXW7,HDAC4,HDAC7,HDAC8,HDAC9,KAT2B,MAML3,MIB1,NBEA,NCOR1,NOTCH1,NUMB,TBL1X,TBL1XR1,TLE1	
Molecular Mechanisms of Cancer	7.06E00	8.76E-02	7.207	ABL1,ACVR2A,ADCY9,ADGRF5,ADGRL3,ADGRL4,AKT3,APC,ARHGEF11,ARHGEF12,ARHGEF3,BCL2,BCL2L1,BMPR2,BRAF,CALCRL,CBL,CCND1,CFLAR,CREBBP,CTNND1,FOXO1,FZD6,GAB1,GAB2,GHR,GNAQ,GPR155,HDAC4,HDAC7,HDAC8,HDAC9,HIPK2,ITGA1,ITGA6,JAK1,JAK2,LEF1,LRP5,MAP2K6,MAPK8,NF1,NFKB1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKDC,PTK2,RAPGEF1,RB1,RBL2,RHOBTB1,RHOJ,SMAD1,SMAD3,SMAD5,SMAD6,SOS1,SOS2,TAB2,TCF4,TCF7L2,TGFB2,TGFBR2,XIAP	
AMPK Signaling	7.03E00	1.32E-01	1.606	ACACA,ACACB,AKT3,ARID1A,ARID2,ATF2,CAB39,CCND1,CREBBP,FOXO1,FOXO3,GNAQ,INSR,KAT2B,PBRM1,PHLPP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1B,PPM1H,PPM1K,PPM1L,PPP2R5E,PRKACB,RPS6KB1,RPTOR,SMARCA2,SMARCA4,SMARCC2,TBC1D1	
Signaling by VEGF	6.99E00	1.85E-01	4.243	AKT3,CTNND1,DOCK1,ELMO1,FLT1,FLT4,ITPR1,ITPR2,KDR,NCKAP1,NRP1,PIK3CA,PIK3R1,PLCG1,PRKACB,PRKCB,PTK2,RICTOR,ROCK1,ROCK2	
MSP-RON Signaling in Cancer Cells Pathway	6.93E00	1.64E-01	4.146	AKT3,ARNT,ATF2,BRAF,CCND1,CREBBP,ELF2,ETS1,ITGA6,LEF1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,RPS6KA3,SOS1,SOS2,SP1,STAT3,TCF4,TCF7L2	
Apelin Endothelial Signaling Pathway	6.87E00	1.63E-01	3.838	ADCY9,AKT3,ARNT,GNAQ,HDAC4,MAPK8,MEF2A,MEF2C,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,SMAD3,SP1	
Acute Myeloid Leukemia Signaling	6.8E00	1.98E-01	4.243	AKT3,BRAF,CCND1,KITLG,LEF1,MAP2K5,MAP2K6,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KB1,SOS1,SOS2,STAT3,TCF4,TCF7L2	
ID1 Signaling Pathway	6.71E00	1.39E-01	3.402	ACVR2A,AKT3,APP,ATF6,BCL2,BCL2L1,BMPR2,BRAF,CCND1,CREBBP,CUL3,ETS1,FGFR2,FOXO3,IGF1R,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD3,SMAD5,STAT3,TGFB2,TGFBR2,TGFBR3,ZNF148	
Docosahexaenoic Acid (DHA) Signaling	6.7E00	1.28E-01	4.950	ADCY9,AKT3,APP,ATF2,BCL2,BCL2L1,BRAF,CCND1,CREBBP,FOXO1,GNAQ,ITPR1,ITPR2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,RPTOR,SPTBN1,STXBP5,STXBP6,TGFB2	
VEGF Family Ligand-Receptor Interactions	6.61E00	2.02E-01	4.000	AKT3,FLT1,FLT4,KDR,NRP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,SOS2	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	6.52E00	1.14E-01	NaN	AKT3,APC,ATF2,CCND1,CREBBP,CSNK1G1,CXCL12,DAAM1,FZD6,GNAQ,JAK2,LEF1,LRP5,MAP2K6,NFAT5,NFKB1,NLK,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,ROCK1,ROCK2,STAT3,TCF4,TCF7L2,TRAF3	
IGF-1 Signaling	6.5E00	1.81E-01	3.500	AKT3,FOXO1,FOXO3,IGF1R,IGFBP7,JAK1,JAK2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,PTK2,RPS6KB1,SOCS7,SOS1,SOS2,STAT3	
PPARÎ±/RXRÎ± Activation	6.48E00	1.39E-01	-2.711	ACVR2A,ADCY9,BMPR2,CLOCK,CREBBP,GHR,GNAQ,INSR,JAK2,MAP2K6,MAP4K4,MAPK8,MEF2C,NCOR1,NFKB1,NR2C2,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,SMAD3,SOS1,SOS2,TGFB2,TGFBR2,TGFBR3	
Glioblastoma Multiforme Signaling	6.46E00	1.46E-01	3.128	AKT3,APC,CCND1,FOXO1,FZD6,IGF1R,ITPR1,ITPR2,LEF1,NF1,NF2,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,RB1,RHOBTB1,RHOJ,RPS6KB1,SOS1,SOS2	
Small Cell Lung Cancer Signaling	6.44E00	1.88E-01	2.887	ABL1,AKT3,BCL2,BCL2L1,CCND1,HDAC4,HDAC7,HDAC8,HDAC9,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,RB1,RBL2,TRAF3	
Sperm Motility	6.43E00	1.25E-01	3.742	ABL1,ABL2,DYRK1A,FER,FGFR2,FLT1,FLT4,GNAQ,IGF1R,INSR,ITPR1,ITPR2,JAK1,JAK2,KDR,LMTK2,MAP2K5,MAP2K6,MERTK,PDE4B,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,PTK2,TNK2	
Huntington's Disease Signaling	6.38E00	1.2E-01	3.411	AKT3,ATF2,BCL2L1,CREBBP,DNM3,GLS,GNAQ,HDAC4,HDAC7,HDAC8,HDAC9,HIP1,HTT,IGF1R,ITPR1,MAPK8,NCOR1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PSME4,RCOR1,SOS1,SOS2,SP1,VTI1A	
CLEAR Signaling Pathway	6.35E00	1.19E-01	0.522	AKT3,ATF2,BMPR2,CREBBP,DEPDC5,FGFR2,FLT1,FLT4,FNIP1,GHR,IGF1R,INSR,ITPR1,ITPR2,KDR,MAP4K3,MID1,PLCG1,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKN,RPTOR,TGFB2,TGFBR2,TGFBR3,UVRAG,VPS8	
Insulin Receptor Signaling	6.31E00	1.57E-01	2.558	AKT3,CBL,CRKL,FOXO1,FOXO3,GAB1,INPP5F,INSR,JAK1,JAK2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP1R12A,PRKACB,RAPGEF1,RPS6KB1,RPTOR,SOS1,SOS2	
GM-CSF Signaling	6.24E00	2.14E-01	3.051	AKT3,BCL2L1,CCND1,ETS1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCB,SOS1,SOS2,STAT3	
Serotonin Receptor Signaling	6.22E00	1E-01	5.397	ADCY9,AKT3,APP,ARFGEF1,ATF2,BCL2,BRAF,CACNA1E,CREBBP,FOXO1,FOXO3,GNAQ,JAK2,KALRN,MAP2K5,MAP2K6,MPDZ,MPRIP,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RB1,RBL2,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KA3,RPS6KB1,SHANK3,STAT3,STIM2,TEAD1,TGFB2	
Nitric Oxide Signaling in the Cardiovascular System	6.21E00	1.67E-01	3.900	AKT3,CACNA1E,FLT1,FLT4,ITPR1,ITPR2,KDR,PDE5A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,SLC7A1	
HER-2 Signaling in Breast Cancer	6.12E00	1.28E-01	3.900	AKT3,BRAF,CCND1,ELF2,ETS1,FOXO1,FOXO3,NFKB1,PARD3,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RB1,RBL2,RPS6KB1,RPTOR,SMAD3,SOS1,SOS2,SP1,STAT3,XIAP	
Signaling by NTRK1 (TRKA)	6.11E00	1.98E-01	4.000	BRAF,CRKL,DNM3,DUSP3,FRS2,KIDINS220,MAP2K5,MEF2A,MEF2C,PIK3CA,PIK3R1,PLCG1,RAPGEF1,RPS6KA3,SOS1,STAT3	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	6.08E00	1.27E-01	NaN	ACVR2A,AKT3,APC,BCL2,BMPR2,CBL,CSNK1G1,FOXO1,FZD6,LEF1,LRP5,MAP2K6,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,SMAD1,SMAD5,SMAD6,SMURF1,TAB2,TCF4,TCF7L2,XIAP	
Thrombopoietin Signaling	6.07E00	2.22E-01	3.742	GAB2,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,STAT3	
Heme signaling	5.98E00	2.55E-01	-2.111	ATF2,CHD9,CLOCK,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,RORA,TBL1X,TBL1XR1	
Ovarian Cancer Signaling	5.96E00	1.46E-01	1.897	ABL1,AKT3,APC,BCL2,BRAF,CCND1,FZD6,GJA1,HDAC4,HDAC7,HDAC8,HDAC9,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,RB1,RBL2,RPS6KB1,TCF4,TCF7L2	
ERK5 Signaling	5.92E00	2.03E-01	3.357	ATF2,CREBBP,ELK4,FOXO3,GAB1,GNAQ,MAP2K5,MAP3K2,MAP3K3,MEF2A,MEF2C,RPS6KA3,RPS6KB1,RPS6KC1,WNK1	
Prolactin Signaling	5.82E00	1.79E-01	3.500	CREBBP,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOCS7,SOS1,SOS2,SP1,STAT3	
Cardiac Hypertrophy Signaling	5.8E00	1.19E-01	5.385	ADCY9,ATF2,CACNA1E,CREBBP,GNAQ,IGF1R,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,MEF2A,MEF2C,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KB1,SOS1,TGFB2,TGFBR2	
IL-8 Signaling	5.8E00	1.29E-01	4.899	AKT3,BCL2,BCL2L1,BRAF,CCND1,FLT1,FLT4,GNAQ,KDR,MAP4K4,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KB1	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	5.77E00	1.23E-01	1.300	AFDN,AKT3,CTNND1,GJA1,IGSF5,ITGA6,LAMA4,LAMC1,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKACB,PRKG1,PTK2,SMAD3,SORBS1,SP1,TGFB2,TGFBR2,TJP1	
TGF-Î² Signaling	5.75E00	1.77E-01	1.807	ACVR2A,BCL2,BMPR2,CREBBP,MAP2K6,MAPK8,SKI,SMAD1,SMAD3,SMAD5,SMAD6,SMURF1,SMURF2,SOS1,SOS2,TGFB2,TGFBR2	
Pulmonary Healing Signaling Pathway	5.74E00	1.31E-01	4.707	BMPR2,BRAF,CCND1,CXCL12,FGFR2,FZD6,KDR,LEF1,MAPK8,NFKB1,NOTCH1,PECAM1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SMAD1,SMAD5,SOS1,SOS2,STAT3,TCF4,TCF7L2,TGFB2,WWTR1	
Adrenomedullin signaling pathway	5.74E00	1.31E-01	4.600	ADCY9,AKT3,ARNT,BCL2,BRAF,CALCRL,GNAQ,ITPR1,ITPR2,MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKG1,PTK2,SMARCC2,SOS1,SOS2	
Erythropoietin Signaling Pathway	5.68E00	1.36E-01	4.082	AKT3,ARNT,BCL2L1,CCND1,FOXO3,ITPR1,ITPR2,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,SOS1,SOS2,TGFB2,XIAP	
ILK Signaling	5.66E00	1.29E-01	3.578	AKT3,ATF2,CCND1,CREBBP,DOCK1,FLNB,LEF1,LIMS1,MAP2K6,MAPK8,MYH10,MYH9,MYO10,MYO18A,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP1R12A,PPP2R5E,PTK2,RHOBTB1,RHOJ,RICTOR	
Telomerase Signaling	5.66E00	1.67E-01	2.111	ABL1,AKT3,ELF2,ETS1,HDAC4,HDAC7,HDAC8,HDAC9,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,RB1,SOS1,SOS2,SP1	
Regulation of lipid metabolism by PPARalpha	5.64E00	1.6E-01	3.357	ARNT,CDK19,CHD9,CLOCK,CREBBP,HMGCS2,MED13,MED13L,MED14,NCOA1,NCOA2,NCOR1,NR1D1,NRF1,RGL1,RORA,SP1,TBL1X,TBL1XR1	
Circadian Clock	5.64E00	2.2E-01	2.496	ATF2,BTRC,CHD9,CLOCK,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,RORA,TBL1X,TBL1XR1	
p53 Signaling	5.62E00	1.73E-01	0.258	AKT3,BCL2,BCL2L1,CCND1,HDAC9,HIPK2,JMY,KAT2B,MAPK8,PIAS1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKDC,RB1,STAG1	
ERK/MAPK Signaling	5.6E00	1.26E-01	3.266	ATF2,BRAF,CREBBP,CRKL,DOCK1,ELF2,ETS1,ITGA1,ITGA6,KSR1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PRKACB,PRKCB,PRKCE,PTK2,RAPGEF1,RAPGEF4,SOS1,SOS2,STAT3	
Autophagy	5.52E00	1.24E-01	1.347	AKT3,AMBRA1,ARNT,ATF2,ATG10,BCL2,BIRC6,CREBBP,FOXO1,FOXO3,INSR,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PRKACB,RB1CC1,RPTOR,TGFB2,TRAF3,UVRAG	
Sertoli Cell-Sertoli Cell Junction Signaling	5.51E00	1.19E-01	4.642	AFDN,AKT3,ATF2,CREBBP,DLG1,EPB41,EPN2,GJA1,IGSF5,ITGA6,LAMA4,LAMC1,MAP3K1,MAP3K2,MAP3K20,MAP3K3,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SORBS1,SPTAN1,SPTBN1,TGFBR2,TJP1,TJP2	
Leukocyte Extravasation Signaling	5.47E00	1.3E-01	3.800	ABL1,AFDN,ARHGAP6,CRKL,CTNND1,CXCL12,DLC1,FER,MAPK8,PECAM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RAPGEF4,ROCK1,ROCK2,WIPF1	
UVB-Induced MAPK Signaling	5.47E00	2.31E-01	3.464	MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KA3,RPS6KB1	
IL-15 Production	5.42E00	1.54E-01	4.359	ABL1,ABL2,DYRK1A,FER,FGFR2,FLT1,FLT4,IGF1R,INSR,JAK1,JAK2,KDR,LMTK2,MAP2K5,MAP2K6,MERTK,NFKB1,PTK2,TNK2	
GÎ±q Signaling	5.41E00	1.35E-01	4.690	AKT3,GNAQ,ITPR1,ITPR2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RHOBTB1,RHOJ,ROCK1,ROCK2	
RANK Signaling in Osteoclasts	5.41E00	1.76E-01	4.000	AKT3,CBL,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,TAB2,XIAP	
Melatonin Signaling	5.34E00	1.94E-01	3.606	BRAF,GNAQ,MAP2K5,MAP2K6,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RORA	
JAK/STAT Signaling	5.33E00	1.83E-01	2.840	AKT3,BCL2L1,GNAQ,JAK1,JAK2,NFKB1,PIAS1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOCS7,SOS1,SOS2,STAT3	
Insulin Secretion Signaling Pathway	5.33E00	1.13E-01	5.568	ADCY9,AGO3,ATF2,CACNA1E,CREBBP,EIF4G1,EIF4G3,GHR,GNAQ,INSR,ITPR1,ITPR2,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RAPGEF4,RPS6KB1,STAT3,VTI1A	
ERBB Signaling	5.28E00	1.72E-01	3.500	FOXO1,MAP2K6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,SOS1,SOS2	
WNT/Î²-catenin Signaling	5.24E00	1.32E-01	0.894	ACVR2A,AKT3,APC,BMPR2,BTRC,CCND1,CREBBP,CSNK1G1,FZD6,GJA1,GNAQ,LEF1,LRP5,MARK2,NLK,PPM1L,PPP2R5E,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3,TLE1	
PEDF Signaling	5.19E00	1.79E-01	1.291	AKT3,BCL2,BCL2L1,CFLAR,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,ROCK2,TCF12,TCF4,TCF7L2,ZEB1	
Glutaminergic Receptor Signaling Pathway (Enhanced)	5.07E00	1.05E-01	5.831	ADCY9,AKT3,ATF2,CACNA1E,CREBBP,DGKD,DGKE,DGKH,GLS,GNAQ,ITPR1,ITPR2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,RPTOR,SHANK3,SLC1A1,TGFB2,VTI1A	
GNRH Signaling	5.05E00	1.26E-01	4.379	ADCY9,ATF2,CACNA1E,CREBBP,GNAQ,ITPR1,ITPR2,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1,PLCB1,PLCB4,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,SOS1,SOS2	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	5.05E00	1.26E-01	3.838	AKT3,CREBBP,JAK1,JAK2,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RHOBTB1,RHOJ	
Leptin Signaling in Obesity	5.05E00	1.84E-01	2.333	ADCY9,AKT3,FOXO1,JAK2,LEPR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,STAT3	
RORA activates gene expression	5.04E00	3.89E-01	2.646	CHD9,CREBBP,NCOA1,NCOA2,RORA,TBL1X,TBL1XR1	
Actin Cytoskeleton Signaling	5.02E00	1.15E-01	2.837	APC,ARHGEF12,CRKL,DOCK1,FGF13,ITGA1,ITGA6,MPRIP,MYH10,MYH9,MYO10,MYO18A,NCKAP1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP1R12A,Ppp1r12b,PTK2,ROCK1,ROCK2,SOS1,SOS2,SSH2,TIAM1,TRIO	
Activin Inhibin Signaling Pathway	5.01E00	1.19E-01	4.315	ACVR2A,AKT3,ATF2,CREBBP,FOXO3,LEF1,MAP2K5,MAP2K6,MAP3K1,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,ROCK2,SKI,SMAD1,SMAD3,SMAD5,STAT3,TCF4,TCF7L2,TGFB2,TGFBR3	
HIPPO signaling	5E00	1.72E-01	-0.378	BTRC,DLG1,FAT4,NF2,PARD3,PPM1L,PPP1R12A,PPP2R5E,SMAD1,SMAD3,SMAD5,STK3,TEAD1,TJP2,WWTR1	
Melanocyte Development and Pigmentation Signaling	4.98E00	1.63E-01	4.000	ADCY9,ATF2,BCL2,CREBBP,KITLG,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,RPS6KA3,RPS6KB1,RPS6KC1,SOS1,SOS2	
DNA Methylation and Transcriptional Repression Signaling	4.98E00	1.63E-01	2.111	CDK12,CDK13,CDK19,CHD4,DNMT3A,MECP2,RB1,RBL2,SAP130,SP1,TCF12,TCF20,TCF4,TEAD1,TET3,ZEB1	
Signaling by Erythropoietin	4.96E00	3.2E-01	2.828	CRKL,GAB1,JAK2,PIK3CA,PIK3R1,PLCG1,RAPGEF1,SOS1	
eNOS Signaling	4.96E00	1.35E-01	4.243	ADCY9,AKT3,FLT1,FLT4,GNAQ,ITPR1,ITPR2,KDR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,SLC7A1	
Acetylcholine Receptor Signaling Pathway	4.94E00	1.24E-01	4.491	ADCY9,AKT3,ATF2,BCL2,CACNA1E,CREBBP,GNAQ,ITPR1,ITPR2,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Apelin Cardiomyocyte Signaling Pathway	4.92E00	1.62E-01	4.000	AKT3,ARNT,ITPR1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
P2Y Purigenic Receptor Signaling Pathway	4.92E00	1.43E-01	4.359	ADCY9,AKT3,ATF2,CREBBP,GNAQ,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Neurotrophin/TRK Signaling	4.92E00	1.79E-01	3.606	ATF2,CREBBP,FRS2,GAB1,MAP2K5,MAP2K6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS1,SOS2	
IL-7 Signaling Pathway	4.92E00	1.79E-01	3.464	AKT3,BCL2,CCND1,EBF1,FOXO1,FOXO3,JAK1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS1,SOS2	
RET signaling	4.89E00	2.44E-01	3.162	FRS2,GAB1,GAB2,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,SHANK3,SOS1	
Axonal Guidance Signaling	4.88E00	9.02E-02	NaN	ABL1,ABLIM1,ADAMTS9,AKT3,ARHGEF11,ARHGEF12,CRKL,CXCL12,DOCK1,FZD6,GNAQ,HERC2,ITGA1,ITGA6,KALRN,LNPEP,NFAT5,NRP1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PLXNA2,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,ROCK1,ROCK2,SEMA3C,SEMA6A,SEMA6D,SOS1,SOS2,SRGAP1,SRGAP2,WIPF1	
CCR3 Signaling in Eosinophils	4.87E00	1.42E-01	3.317	GNAQ,ITPR1,ITPR2,MPRIP,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,ROCK1,ROCK2	
HIF1Î± Signaling	4.86E00	1.2E-01	5.000	AKT3,ARNT,BRAF,CREBBP,FLT1,FLT4,KDR,MAP2K5,MAP2K6,NCOA1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,STAT3,TGFB2	
Endocannabinoid Cancer Inhibition Pathway	4.82E00	1.36E-01	-3.130	ADCY9,AKT3,ATF2,CCND1,CREBBP,GNAQ,LEF1,MAP2K5,MAP2K6,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,PTK2,ROCK1,ROCK2,RPTOR,TCF4,TCF7L2	
Signaling by BMP	4.82E00	3.08E-01	2.828	ACVR2A,BMPR2,SKI,SMAD1,SMAD5,SMAD6,SMURF1,SMURF2	
Aldosterone Signaling in Epithelial Cells	4.81E00	1.28E-01	4.359	DNAJC1,DNAJC13,ITPR1,ITPR2,NR3C2,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCB1,PLCB4,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SASS6,SOS1,SOS2	
Dopamine-DARPP32 Feedback in cAMP Signaling	4.76E00	1.24E-01	4.264	ADCY9,ATF2,CACNA1E,CREBBP,CSNK1G1,GNAQ,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PPM1L,PPP1R12A,PPP2R5E,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1	
Beta-catenin independent WNT signaling	4.75E00	1.57E-01	2.138	AGO3,DAAM1,FZD6,ITPR1,ITPR2,LEF1,NLK,PLCB1,PPP3CA,PRKCB,PRKG1,SMURF1,SMURF2,TCF7L2,TNRC6A,TNRC6B	
Opioid Signaling Pathway	4.74E00	1.07E-01	3.922	ADCY9,AKT3,ATF2,BRAF,CACNA1E,CREBBP,GNAQ,GRK5,ITPR1,ITPR2,LEF1,MAP2K5,MAP2K6,NFKB1,PLCB1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RGS5,RPS6KA3,RPS6KB1,SOS1,SOS2,TCF4,TCF7L2	
RAC Signaling	4.73E00	1.39E-01	4.000	ELK4,ITGA1,ITGA6,MAP3K1,MAPK8,MCF2L,NCKAP1,NFKB1,PARD3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PTK2,RPS6KB1,SH3RF1,TIAM1	
PI3K/AKT Signaling	4.71E00	1.2E-01	1.807	AKT3,BCL2,BCL2L1,CCND1,FOXO1,FOXO3,GAB1,GAB2,GHR,INPP5F,ITGA1,ITGA6,JAK1,JAK2,LIMS1,NFKB1,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,RPS6KB1,SOS1,SOS2	
Signaling by SCF-KIT	4.69E00	2.33E-01	3.162	CBL,FER,GAB2,JAK2,KITLG,PIK3CA,PIK3R1,PIK3R3,SOS1,STAT3	
FLT3 Signaling in Hematopoietic Progenitor Cells	4.66E00	1.71E-01	3.742	AKT3,ATF2,CBL,CREBBP,GAB2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KA3,RPS6KB1,SOS1,SOS2,STAT3	
Transcriptional Regulatory Network in Embryonic Stem Cells	4.62E00	1.28E-01	3.273	ACVR2A,AKT3,BMPR2,FGFR2,FZD6,IGF1R,JAK1,JAK2,KAT6A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD3,SMAD5,STAT3,TGFB2,TGFBR2,TGFBR3,ZFHX3	
Colorectal Cancer Metastasis Signaling	4.6E00	1.07E-01	4.379	ADCY9,AKT3,APC,BCL2L1,BRAF,CCND1,FZD6,GNAQ,JAK1,JAK2,LEF1,LRP5,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,RHOBTB1,RHOJ,SMAD3,SOS1,SOS2,STAT3,TCF4,TCF7L2,TGFB2,TGFBR2	
Transcriptional Regulation by MECP2	4.57E00	1.9E-01	0.447	AGO3,HIPK2,HTT,MECP2,MEF2C,NCOR1,NOTCH1,PTPN4,TBL1X,TBL1XR1,TNRC6A,TNRC6B	
Transcriptional regulation of white adipocyte differentiation	4.54E00	1.67E-01	3.207	CDK19,CHD9,CREBBP,EBF1,MED13,MED13L,MED14,NCOA1,NCOA2,NCOR1,NFKB1,TBL1X,TBL1XR1,ZNF638	
Fc Epsilon RI Signaling	4.52E00	1.44E-01	3.638	AKT3,GAB1,INPP5F,MAP2K6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,SOS2	
Hereditary Breast Cancer Signaling	4.51E00	1.34E-01	NaN	AKT3,ARID1A,ARID2,CCND1,CREBBP,FANCC,HDAC4,HDAC7,HDAC8,HDAC9,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1,SMARCA2,SMARCA4,SMARCC2	
Transcriptional regulation by RUNX3	4.47E00	1.56E-01	3.317	CCND1,CREBBP,FOXO3,HDAC4,KAT2B,LEF1,MAML3,NOTCH1,SMAD3,SMURF1,SMURF2,TCF7L2,TEAD1,WWTR1,ZFHX3	
Xenobiotic Metabolism General Signaling Pathway	4.47E00	1.33E-01	3.900	AKT3,ARNT,CREBBP,CUL3,MAP2K5,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
fMLP Signaling in Neutrophils	4.46E00	1.37E-01	4.123	GNAQ,ITPR1,ITPR2,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Interleukin-3, Interleukin-5 and GM-CSF signaling	4.44E00	2E-01	3.317	CBL,CRKL,GAB2,INPP5F,JAK1,JAK2,PIK3CA,PIK3R1,PIK3R3,RAPGEF1,SOS1	
Myogenesis	4.43E00	2.76E-01	2.828	ABL1,MAP2K6,MEF2A,MEF2C,NEO1,SPAG9,TCF12,TCF4	
Deubiquitination	4.42E00	1.06E-01	5.292	APC,ASXL2,ATXN7,BABAM2,IDE,IFIH1,INO80D,KAT2B,MBD5,OTUD7B,PRKN,PSME4,SMAD1,SMAD3,SMURF2,TGFBR2,TNKS,TNKS2,TRAF3,TRIM25,USP24,USP25,USP3,USP34,USP37,USP47,USP7,USP9X	
Superpathway of Inositol Phosphate Compounds	4.4E00	1.1E-01	4.583	ATP1A2,INPP5A,INPP5F,IP6K1,ITPKB,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCB1,PLCB4,PLCG1,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
Germ Cell-Sertoli Cell Junction Signaling	4.39E00	1.24E-01	NaN	AFDN,CTNND1,EPN2,FER,ITGA6,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,RHOBTB1,RHOJ,SORBS1,TGFB2,TGFBR2,TJP1	
UVA-Induced MAPK Signaling	4.37E00	1.53E-01	3.000	BCL2L1,MAPK8,PARP14,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,RPS6KA3,RPS6KB1,RPS6KC1,TNKS,TNKS2	
Orexin Signaling Pathway	4.34E00	1.09E-01	4.315	ADCY9,AKT3,CACNA1E,FOXO1,GNAQ,ITPR1,ITPR2,NFKB1,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPTOR,SMAD1,SMAD5	
Eicosanoid Signaling	4.34E00	1.04E-01	5.292	ABCC4,ADCY9,AKT3,AP1G1,ATF2,BRAF,CCND1,CREBBP,ETS1,GNAQ,LEF1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RAPGEF4,RPS6KA3,TCF4,TCF7L2	
RAR Activation	4.3E00	9.09E-02	5.284	ACVR2A,ADCY9,Akr1c14,AKT3,ARID1A,ARID2,ATF2,BMPR2,CREBBP,GNAQ,JAK2,KAT2B,MAP3K1,MAPK8,MNAT1,NCOA1,NCOR1,NFKB1,PBRM1,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,RHOBTB1,RHOJ,SMAD3,SMARCA2,SMARCA4,SMARCC2,SP1,TGFB2,TGFBR2,TGFBR3	
NF-ÎºB Activation by Viruses	4.25E00	1.67E-01	3.606	AKT3,ITGA6,MAP3K1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
HEY1 Signaling Pathway	4.25E00	1.24E-01	4.025	ACVR2A,AKT3,ARNT,BMPR2,DLL4,GAB1,MEF2C,NCOR1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD3,SMAD5,SMAD6,TGFB2,TGFBR2,TGFBR3	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	4.24E00	1.37E-01	3.317	ACVR2A,AKT3,APC,BMPR2,FZD6,GAB1,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD5,SOS1,SOS2,STAT3	
RHOA Signaling	4.24E00	1.37E-01	1.500	ABL2,ARHGAP6,ARHGEF11,ARHGEF12,DLC1,IGF1R,MPRIP,PI4KA,PIKFYVE,PKN1,PPP1R12A,Ppp1r12b,PTK2,RAPGEF2,RAPGEF6,ROCK1,ROCK2	
ERBB4 Signaling	4.22E00	1.76E-01	3.464	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,SOS2	
Neuropathic Pain Signaling in Dorsal Horn Neurons	4.21E00	1.49E-01	3.873	ITPR1,ITPR2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
HOTAIR Regulatory Pathway	4.17E00	1.23E-01	3.578	AGO3,AKT3,ATXN1,CREBBP,JARID2,KMT2A,KMT2C,LEF1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RCOR1,ROCK1,ROCK2,STAT3,TCF4,TCF7L2,XIAP	
Cell Cycle: G1/S Checkpoint Regulation	4.16E00	1.74E-01	0.000	ABL1,BTRC,CCND1,FOXO1,HDAC4,HDAC7,HDAC8,HDAC9,RB1,RBL2,SMAD3,TGFB2	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	4.16E00	1.07E-01	-1.043	ACVR2A,AKT3,APC,BCL2,BMPR2,CSNK1G1,CXCL12,FZD6,IGF1R,JAK1,JAK2,LEF1,LRP5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMAD1,SMAD5,SMAD6,SMURF1,SMURF2,STAT3,TCF4,TCF7L2,TGFB2	
Class I MHC mediated antigen processing and presentation	4.15E00	9.33E-02	5.916	BTRC,CANX,CBLB,CUL3,FBXL7,FBXO11,FBXW11,FBXW7,HECTD1,HERC1,HERC2,HERC4,HERC6,HUWE1,KLHL2,KLHL3,LMO7,LNPEP,NEDD4L,PRKN,PSME4,RNF144B,RNF213,SH3RF1,SMURF1,SMURF2,TRIP12,UBE2H,UBE3A,UBE3C,UBE4A,UBR1,UBR4,ZNRF1,ZNRF2	
14-3-3-mediated Signaling	4.1E00	1.34E-01	3.742	AKT3,CBL,FOXO1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SRPK2	
Transcriptional regulation by RUNX1	4.1E00	1.25E-01	4.359	ABL1,ARID1A,ARID1B,ARID2,CREBBP,ELF2,HIPK2,KMT2A,MNAT1,PBRM1,PHC3,PRKCB,PSME4,SCMH1,SMARCA2,SMARCA4,SMARCC2,TCF12,TJP1	
Signaling by FGFR1	4.09E00	2E-01	3.162	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,SOS1,SPRED1,SPRED2	
FAT10 Cancer Signaling Pathway	4.09E00	2E-01	3.000	ACVR2A,AKT3,BMPR2,NFKB1,SMAD3,STAT3,TCF7L2,TGFB2,TGFBR2,TGFBR3	
Type II Diabetes Mellitus Signaling	4.06E00	1.24E-01	3.606	ACSL3,AKT3,CACNA1E,INSR,ITPR1,ITPR2,MAP3K1,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOCS7	
Tumor Microenvironment Pathway	4.06E00	1.17E-01	3.710	AKT3,BCL2,BRAF,CCND1,CFLAR,CXCL12,FGF13,FOXO1,FOXO3,JAK2,LEPR,NFKB1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SLC16A1,STAT3,TGFB2,TIAM1	
RAF/MAP kinase cascade	4.04E00	1.03E-01	5.196	BRAF,CUL3,DLG1,FGFR2,FRS2,JAK1,JAK2,KITLG,KSR1,MARK3,NF1,PIK3CA,PIK3R1,PPP2R5E,PSME4,PTK2,PTPRA,RANBP9,RAPGEF2,RASAL2,RASGRP3,RGL1,SOS1,SPRED1,SPRED2,SPTAN1,SPTBN1	
Neuregulin Signaling	4.01E00	1.37E-01	3.464	AKT3,CRKL,ERBIN,ITGA1,ITGA6,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,SOS1,SOS2	
Biotin-carboxyl Carrier Protein Assembly	4.01E00	1E00	NaN	ACACA,ACACB,HLCS	
Signaling by NTRK2 (TRKB)	3.99E00	2.8E-01	2.646	FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,SOS1,TIAM1	
Formation of WDR5-containing histone-modifying complexes	3.98E00	2.14E-01	3.000	BOD1L1,KANSL1,KAT2B,KDM6A,KMT2A,KMT2C,KMT2D,PHF20,ZZZ3	
Synaptic Long Term Potentiation	3.89E00	1.29E-01	3.638	ATF2,CREBBP,GNAQ,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PPP1R12A,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Circadian Rhythm Signaling	3.88E00	1.01E-01	NaN	ADCY9,ATF2,BRAF,BTRC,CACNA1E,CLOCK,CREBBP,GNAQ,HLF,ITPR1,ITPR2,MAP2K5,MAP2K6,NR1D1,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,RORA,RPTOR,SMARCC2	
LPS-stimulated MAPK Signaling	3.86E00	1.53E-01	3.051	ATF2,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Mitochondrial biogenesis	3.81E00	1.72E-01	2.111	ATF2,CHD9,CREBBP,MEF2C,NCOA1,NCOA2,NCOR1,NR1D1,NRF1,TBL1X,TBL1XR1	
Semaphorin interactions	3.81E00	1.72E-01	3.317	ARHGEF11,ARHGEF12,ITGA1,MYH10,MYH9,NRP1,PLXNA2,ROCK1,ROCK2,SEMA6A,SEMA6D	
Synaptogenesis Signaling Pathway	3.8E00	9.52E-02	4.747	ADCY9,AFDN,AKT3,ATF2,BRAF,CADM1,CLASP2,CREBBP,CRKL,CTNND1,FARP1,ITPR1,ITSN2,KALRN,LRP8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKACB,PRKCE,RAPGEF1,RPS6KB1,SOS1,SOS2,STXBP5,STXBP6,TIAM1,VTI1A	
STAT3 Pathway	3.77E00	1.26E-01	3.638	BCL2,BMPR2,FGFR2,FLT1,FLT4,GHR,IGF1R,INSR,JAK2,KDR,MAP3K20,MAPK8,SOCS7,STAT3,TGFB2,TGFBR2,TGFBR3	
Effects of PIP2 hydrolysis	3.76E00	2.59E-01	2.646	DGKD,DGKE,DGKH,ITPR1,ITPR2,PRKCE,PRKCH	
BMAL1:CLOCK,NPAS2 activates circadian gene expression	3.76E00	2.59E-01	2.646	CHD9,CLOCK,CREBBP,NCOA1,NCOA2,TBL1X,TBL1XR1	
Cardiomyocyte Differentiation via BMP Receptors	3.76E00	2.59E-01	1.000	ACVR2A,ATF2,BMPR2,MEF2C,SMAD1,SMAD5,SMAD6	
Ephrin Receptor Signaling	3.75E00	1.09E-01	4.243	ABL1,AKT3,ATF2,CREBBP,CRKL,CXCL12,GNAQ,ITGA1,ITGA6,JAK2,KALRN,MAP4K4,PDGFD,PTK2,RAPGEF1,ROCK1,ROCK2,SORBS1,SOS1,SOS2,STAT3,WIPF1	
Protein Ubiquitination Pathway	3.75E00	9.89E-02	NaN	BIRC6,BTRC,CBL,DNAJC1,DNAJC13,FBXW7,NEDD4L,PRKN,SASS6,SMURF1,SMURF2,UBE2H,UBE3A,UBE4A,UBE4B,UBR1,USP24,USP25,USP3,USP32,USP34,USP37,USP47,USP54,USP7,USP9X,XIAP	
GDNF Family Ligand-Receptor Interactions	3.74E00	1.58E-01	3.000	FRS2,GAB1,ITPR1,ITPR2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SOS1,SOS2	
Macropinocytosis Signaling	3.74E00	1.58E-01	3.162	PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,USP6NL	
FLT3 Signaling	3.71E00	2.22E-01	2.828	ABL2,AKT3,CBL,FOXO3,GAB2,PIK3CA,PIK3R1,SOS1	
G-Protein Coupled Receptor Signaling	3.71E00	7.68E-02	5.171	ADCY9,ADGRF5,ADGRL3,ADGRL4,AKT3,ATF2,BRAF,CALCRL,CCND1,CREBBP,FOXO1,FOXO3,FZD6,GNAQ,GPR155,GRK5,MAP2K5,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,MEF2A,MEF2C,MEGF6,NFAT5,NFKB1,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PREX2,PRKACB,PRKCB,PRKCE,PTK2,RAPGEF1,RAPGEF4,ROCK1,ROCK2,SOS1,SOS2,STAT3,WWTR1	
Dilated Cardiomyopathy Signaling Pathway	3.69E00	1.2E-01	-0.535	ADCY9,AKT3,BCL2,CACNA1E,GAB1,ITPR1,ITPR2,KDM5A,LAMA4,MAP3K3,MYH10,MYH9,MYO10,MYO18A,PRKACB,PRKCE,RBM20,UTRN	
PTEN Regulation	3.69E00	1.2E-01	3.162	AGO3,AKT3,ATF2,CHD4,HDAC7,MECOM,PHC3,PREX2,PSME4,RCOR1,RPTOR,SCMH1,TNKS,TNKS2,TNRC6A,TNRC6B,USP7,XIAP	
Cellular Effects of Sildenafil (Viagra)	3.69E00	1.2E-01	NaN	ADCY9,CACNA1E,ITPR1,ITPR2,MPRIP,MYH10,MYH9,MYO10,MYO18A,PDE4B,PDE5A,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKACB,PRKG1	
Interleukin-2 family signaling	3.66E00	1.96E-01	3.000	GAB2,INPP5F,JAK1,JAK2,PIK3CA,PIK3R1,PIK3R3,SOS1,STAT3	
IL-23 Signaling Pathway	3.66E00	1.96E-01	3.000	AKT3,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RORA,STAT3	
Reelin Signaling in Neurons	3.66E00	1.23E-01	4.000	AFDN,AKT3,APP,ARHGEF11,ARHGEF12,ARHGEF3,CRKL,DNAH3,LRP8,MAP2K5,MAP2K6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RAPGEF1	
VDR/RXR Activation	3.63E00	1.54E-01	-2.333	FOXO1,LRP5,NCOA1,NCOA2,NCOR1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SP1,TGFB2	
Corticotropin Releasing Hormone Signaling	3.62E00	1.18E-01	3.357	ADCY9,ATF2,BRAF,CACNA1E,CREBBP,GNAQ,ITPR1,ITPR2,MEF2A,MEF2C,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SMARCC2	
Autism Signaling Pathway	3.61E00	9.42E-02	3.528	AKT3,APC,BRAF,CACNA1E,CHD8,CREBBP,FZD6,IGF1R,LEF1,LRP5,MECP2,NF1,PCCA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1K,PRKACB,RPS6KB1,RPS6KC1,RPTOR,SHANK3,SOS1,SOS2,TCF4,TCF7L2,TGFB2,UBE3A	
CNTF Signaling	3.59E00	1.75E-01	3.162	JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KA3,RPS6KB1,SOS1,STAT3	
GP6 Signaling Pathway	3.59E00	1.26E-01	3.873	AKT3,COL4A2,ITPR1,LAMA4,LAMC1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2	
Endocannabinoid Developing Neuron Pathway	3.59E00	1.26E-01	3.357	ADCY9,AKT3,ATF2,BRAF,CCND1,CREBBP,MAP2K5,MAP2K6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,RPTOR,STAT3	
Signaling by MET	3.58E00	1.52E-01	3.464	CBL,CRKL,GAB1,LAMA4,LAMC1,PIK3CA,PIK3R1,PTK2,RANBP9,RAPGEF1,SOS1,STAT3	
Renal Cell Carcinoma Signaling	3.58E00	1.52E-01	3.162	AKT3,ARNT,CREBBP,ETS1,GAB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RAPGEF1,SOS1,SOS2	
Thyroid Cancer Signaling	3.58E00	1.52E-01	2.887	AKT3,BRAF,CCND1,FOXO1,INSR,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TCF4,TCF7L2	
Endothelin-1 Signaling	3.57E00	1.08E-01	4.025	ADCY9,BRAF,ECE1,GAB1,GNAQ,ITPR1,ITPR2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1	
BMP signaling pathway	3.56E00	1.43E-01	2.309	ACVR2A,ATF2,BMPR2,CREBBP,MAPK8,NFKB1,PRKACB,SMAD1,SMAD5,SMAD6,SMURF1,SOS1,XIAP	
Sumoylation Pathway	3.55E00	1.36E-01	-0.302	CREBBP,DNMT3A,ETS1,MAPK8,NFKB1,PIAS1,RCOR1,RHOBTB1,RHOJ,SENP6,SENP7,SP1,XIAP,ZEB1	
TR/RXR Activation	3.55E00	1.25E-01	3.000	ACACA,AKT3,CCND1,NCOA1,NCOA2,NCOR1,NRF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RCAN2,RPS6KB1,SLC16A2,STRBP,TBL1XR1	
Interleukin-7 signaling	3.54E00	2.86E-01	2.449	BRWD1,JAK1,PIK3R1,PIK3R3,SMARCA4,STAT3	
Interleukin-15 signaling	3.53E00	3.57E-01	2.236	GAB2,JAK1,SOS1,SOS2,STAT3	
G alpha (12/13) signalling events	3.53E00	1.5E-01	3.464	AKAP13,ARHGEF11,ARHGEF12,ARHGEF3,KALRN,MCF2L,ROCK1,ROCK2,SOS1,SOS2,TIAM1,TRIO	
Androgen Signaling	3.49E00	1.12E-01	2.138	CACNA1E,CCND1,CREBBP,GNAQ,ITPR1,ITPR2,KAT2B,MNAT1,NCOA1,NCOA2,NFKB1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SMAD3,TAF3	
Chemokine Signaling	3.47E00	1.48E-01	1.732	CXCL12,GNAQ,MAPK8,MPRIP,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PRKCB,PTK2,ROCK2	
NAFLD Signaling Pathway	3.46E00	1.02E-01	1.877	ACACA,ACACB,AKT3,ATF6,FOXO1,FOXO3,INSR,JAK1,JAK2,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKCE,RPTOR,SOCS7,STAT3,TBC1D1,TGFB2	
ESR-mediated signaling	3.44E00	1.27E-01	2.324	AGO3,ATF2,BCL2,CCND1,CREBBP,CXCL12,KAT2B,NCOA1,NCOA2,POU2F1,RAD21,SP1,STAG1,TNRC6A,TNRC6B	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	3.44E00	1.27E-01	3.873	ADCY9,CACNA1E,GNAQ,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RAPGEF4	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	3.44E00	1.84E-01	2.828	NCOR1,NEDD4L,SKI,SMAD3,SMURF2,SP1,TRIM33,USP9X,WWTR1	
TCF dependent signaling in response to WNT	3.42E00	1.06E-01	4.583	APC,BTRC,CHD8,CREBBP,CUL3,FZD6,KMT2D,LEF1,LRP5,PPP2R5E,PSME4,SMARCA4,SMURF2,TCF4,TCF7L2,TLE1,TNKS,TNKS2,USP34,XIAP,ZNRF3	
FcÎ³ Receptor-mediated Phagocytosis in Macrophages and Monocytes	3.42E00	1.38E-01	3.051	AKT3,CBL,DOCK1,GAB2,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1	
Endometrial Cancer Signaling	3.4E00	1.67E-01	2.333	AKT3,CCND1,FOXO3,LEF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2	
GADD45 Signaling	3.4E00	1.67E-01	1.897	ACVR2A,CCND1,FOXO3,MAP2K6,MAPK8,NFKB1,POU2F1,SMAD3,TGFB2,TGFBR2	
Neuroinflammation Signaling Pathway	3.4E00	9.15E-02	4.158	ACVR2A,AKT3,APP,ATF2,BCL2,BIRC6,BMPR2,CFLAR,CREBBP,CXCL12,GLS,IDE,JAK1,JAK2,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,TGFB2,TGFBR2,TGFBR3,TRAF3,XIAP	
mTOR Signaling	3.39E00	1.03E-01	3.771	AKT3,EIF4G1,EIF4G3,INSR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RHOBTB1,RHOJ,RICTOR,RPS6KA3,RPS6KB1,RPS6KC1,RPTOR	
Signaling by FGFR3	3.38E00	2E-01	2.828	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,SOS1	
Transcriptional Regulation by VENTX	3.38E00	2E-01	-0.816	AGO3,CCND1,EHMT1,LEF1,NFKB1,TCF7L2,TNRC6A,TNRC6B	
Signaling by ERBB2	3.37E00	1.8E-01	3.000	AKT3,ERBIN,GAB1,MEMO1,PIK3CA,PIK3R1,PLCG1,PRKCE,SOS1	
YAP1- and WWTR1 (TAZ)-stimulated gene expression	3.37E00	3.33E-01	2.236	HIPK1,HIPK2,KAT2B,TEAD1,WWTR1	
Mitotic Telophase/Cytokinesis	3.37E00	3.33E-01	2.236	NIPBL,PDS5A,PDS5B,RAD21,STAG1	
Sphingosine-1-phosphate Signaling	3.36E00	1.25E-01	3.051	ACER2,ADCY9,AKT3,GNAQ,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PTK2,RHOBTB1,RHOJ	
Signaling by CSF1 (M-CSF) in myeloid cells	3.36E00	2.26E-01	2.646	CBL,GAB2,GAB3,PIK3CA,PIK3R1,SOS1,STAT3	
Transcriptional regulation by RUNX2	3.31E00	1.76E-01	2.333	ABL1,AKT3,CCND1,HDAC4,RB1,SMAD1,SMAD6,WWTR1,ZNF521	
Activation of gene expression by SREBF (SREBP)	3.3E00	1.95E-01	2.828	ACACB,CHD9,CREBBP,NCOA1,NCOA2,SP1,TBL1X,TBL1XR1	
Signaling by FGFR4	3.3E00	1.95E-01	2.828	BRAF,CBL,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,SOS1	
Cyclins and Cell Cycle Regulation	3.23E00	1.4E-01	-1.000	ABL1,BTRC,CCND1,HDAC4,HDAC7,HDAC8,HDAC9,PPM1L,PPP2R5E,RB1,RBL2,TGFB2	
Signaling by Rho Family GTPases	3.16E00	9.36E-02	3.441	ARHGEF11,ARHGEF12,ARHGEF3,CLIP1,GNAQ,ITGA1,ITGA6,MAP3K20,MAPK8,NFKB1,PARD3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PKN1,PPP1R12A,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,WIPF1	
ERB2-ERBB3 Signaling	3.12E00	1.54E-01	2.530	CCND1,FOXO1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2,SP1,STAT3	
Pyridoxal 5'-phosphate Salvage Pathway	3.12E00	1.54E-01	3.162	ACVR2A,BRAF,DYRK1A,GRK5,HIPK1,MAP2K6,MAPK8,PKN1,PRKCE,PRKCH	
RAB GEFs exchange GTP for GDP on RABs	3.1E00	1.35E-01	3.464	AKT3,DENND1A,DENND1B,DENND4C,DENND5A,DENND5B,GAPVD1,RAB31,RIC1,RIN2,SBF2,TRAPPC9	
Lymphotoxin Î² Receptor Signaling	3.06E00	1.64E-01	2.646	AKT3,BCL2L1,CREBBP,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TRAF3	
IL-9 Signaling	3.02E00	2E-01	2.646	JAK1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
CD40 Signaling	3.01E00	1.49E-01	3.162	MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3,TRAF3	
IL-17A Signaling in Airway Cells	3.01E00	1.49E-01	3.162	AKT3,JAK1,JAK2,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Ceramide Signaling	3.01E00	1.32E-01	-0.302	AKT3,BCL2,KSR1,MAP3K1,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E	
Role of BRCA1 in DNA Damage Response	2.95E00	1.38E-01	2.000	ARID1A,ARID2,BABAM2,FANCC,PBRM1,POU2F1,RB1,RBL2,SMARCA2,SMARCA4,SMARCC2	
Virus Entry via Endocytic Pathways	2.95E00	1.19E-01	NaN	ABL1,AP1G1,AP3B1,FLNB,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	2.93E00	8.77E-02	4.426	AKT3,ATF2,BCL2,BRAF,CBL,CCND1,COL4A2,CREBBP,FOXO1,FOXO3,MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,RHOBTB1,RHOJ,SOS1,SOS2,TAB2,XIAP	
Signaling by PDGF	2.89E00	1.55E-01	3.000	COL4A2,CRKL,PDGFD,PIK3CA,PIK3R1,PLCG1,RAPGEF1,SOS1,STAT3	
Cancer Drug Resistance by Drug Efflux	2.89E00	1.55E-01	3.000	ABCB1,AKT3,BRAF,FOXO1,FOXO3,NFKB1,PIK3CA,PIK3R1,PIK3R3	
Estrogen-Dependent Breast Cancer Signaling	2.87E00	1.34E-01	3.317	AKT3,ATF2,CCND1,CREBBP,IGF1R,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SP1	
BEX2 Signaling Pathway	2.87E00	1.34E-01	2.111	AKT3,BCL2,CCND1,LEF1,MAPK8,NFKB1,PPM1L,PPP2R5E,STAT3,TCF4,TCF7L2	
Calcium Signaling	2.85E00	9.55E-02	3.317	ATF2,CACNA1E,CREBBP,HDAC4,HDAC7,HDAC8,HDAC9,ITPR1,ITPR2,MCU,MEF2A,MEF2C,MYH10,MYH9,MYO10,MYO18A,NFAT5,PPP3CA,PPP3CC,PRKACB,RCAN2	
RHO GTPases Activate ROCKs	2.85E00	2.63E-01	2.236	MYH10,MYH9,PPP1R12A,ROCK1,ROCK2	
FOXO-mediated transcription	2.85E00	2.63E-01	2.236	AKT3,CREBBP,FOXO1,FOXO3,KAT2B	
Osteoarthritis Pathway	2.83E00	9.32E-02	2.065	ATF2,BMPR2,CREBBP,EPAS1,FOXO3,FZD6,HDAC4,ITGA1,ITGA6,LEF1,MEF2C,NFKB1,NOTCH1,SIK3,SMAD1,SMAD3,SMAD5,SMAD6,SP1,TCF4,TCF7L2,TGFBR2	
Clathrin-mediated Endocytosis Signaling	2.78E00	9.62E-02	NaN	AAK1,AP1G1,AP3B1,CBL,DAB2,DNM3,FGF13,HIP1,MYO1E,MYO6,NUMB,PDGFD,PICALM,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,USP9X	
3-phosphoinositide Biosynthesis	2.78E00	9.62E-02	3.873	ATP1A2,INPP5F,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
Signaling by Hippo	2.74E00	2.5E-01	2.236	AMOTL1,STK3,TJP1,TJP2,WWTR1	
Signaling by FGFR2	2.72E00	1.37E-01	3.162	BRAF,CBL,FGFR2,FRS2,GAB1,PIK3CA,PIK3R1,PLCG1,RBFOX2,SOS1	
Netrin-1 signaling	2.71E00	1.6E-01	2.828	ABLIM1,DOCK1,MAPK8,MYO10,NEO1,PLCG1,PTK2,TRIO	
NR1H2 and NR1H3-mediated signaling	2.71E00	1.6E-01	0.707	AGO3,KDM3A,NCOA1,NCOR1,TBL1X,TBL1XR1,TNRC6A,TNRC6B	
Melanoma Signaling	2.71E00	1.6E-01	2.121	AKT3,BRAF,CCND1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1	
Cachexia Signaling Pathway	2.7E00	8.15E-02	1.461	ACVR2A,ADCY9,AGO3,AKT3,BCL2,BMPR2,FOXO1,FOXO3,IGF1R,INSR,MAPK8,MEF2C,MFN1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PSME4,SMAD3,STAT3,TGFB2,TGFBR2,TGFBR3	
IL-2 Signaling	2.68E00	1.45E-01	2.828	AKT3,JAK1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2	
PIP3 activates AKT signaling	2.67E00	1.07E-01	3.873	AKT3,FGFR2,FOXO1,FOXO3,FRS2,GAB1,GAB2,INSR,KITLG,PHLPP1,PIK3CA,PIK3R1,PIK3R3,PPP2R5E,RICTOR	
p75 NTR receptor-mediated signalling	2.65E00	1.2E-01	3.464	AKAP13,ARHGEF11,ARHGEF12,ARHGEF3,KALRN,MAPK8,MCF2L,NFKB1,SOS1,SOS2,TIAM1,TRIO	
Relaxin Signaling	2.65E00	1.03E-01	3.000	ADCY9,AKT3,BRAF,GNAQ,NFKB1,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,SMARCC2	
Oxytocin in Brain Signaling Pathway	2.64E00	9.55E-02	3.900	AKT3,ATF2,CACNA1E,CREBBP,GNAQ,ITPR1,ITPR2,MEF2A,MEF2C,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Cleavage and Polyadenylation of Pre-mRNA	2.63E00	3.08E-01	NaN	CPSF6,CSTF3,PAPOLA,WDR33	
DAG and IP3 signaling	2.6E00	1.71E-01	2.236	ADCY9,ITPR1,ITPR2,NBEA,PLCG1,PRKACB,PRKCE	
Angiopoietin Signaling	2.59E00	1.32E-01	2.236	AKT3,FOXO1,GRB14,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS1	
G Beta Gamma Signaling	2.58E00	1.09E-01	3.464	AKT3,CACNA1E,GNAQ,ITPR1,ITPR2,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,SOS2	
IL-6 Signaling	2.58E00	1.09E-01	3.742	ABCB1,AKT3,JAK2,MAP2K6,MAP4K4,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2,STAT3	
Xenobiotic Metabolism Signaling	2.58E00	8.5E-02	NaN	ABCB1,ARNT,CHST11,CREBBP,CUL3,HDAC4,MAP2K5,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,NCOA1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Signaling by ROBO receptors	2.56E00	1.12E-01	3.606	ABL1,ABL2,CLASP1,CLASP2,CXCL12,EVL,NRP1,PRKACB,PSME4,SOS1,SOS2,SRGAP1,SRGAP2	
Signaling by TGF-beta Receptor Complex	2.55E00	1.51E-01	2.828	CBL,NEDD4L,PARD3,SMAD3,SMURF1,SMURF2,TGFB2,TGFBR2	
Mitotic Prometaphase	2.54E00	9.36E-02	4.359	ALMS1,CEP250,CLASP1,CLASP2,CLIP1,CNTRL,DYNC1H1,EML4,HDAC8,MAD1L1,NEK7,NUMA1,PCM1,PDS5A,PDS5B,PPP2R5E,RAD21,STAG1,TAOK1	
Opioid Signalling	2.54E00	1.22E-01	3.000	ADCY9,GNAQ,ITPR1,ITPR2,NBEA,PDE4B,PLCB1,PLCB4,PPP3CA,PPP3CC,PRKACB	
Coronavirus Pathogenesis Pathway	2.52E00	9.31E-02	-2.065	ABL1,BCL2,CCND1,HDAC4,HDAC7,HDAC8,HDAC9,JAK1,MAPK8,NFKB1,PIKFYVE,RB1,RBL2,SMAD3,STAT3,TGFBR2,TNPO1,TRAF3,TRIM25	
Glucocorticoid Receptor Signaling	2.51E00	7.22E-02	NaN	AKT3,ARID1A,ARID2,BCL2,BCL2L1,CREBBP,DCAF6,DNAH3,FOXO3,GHR,GJA1,JAK1,JAK2,KAT2B,MAP3K1,MAPK8,MED14,MNAT1,NCOA1,NCOA2,NCOR1,NFAT5,NFKB1,NR3C2,PBRM1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKACB,SMAD3,SMARCA2,SMARCA4,SMARCC2,SOS1,SOS2,STAT3,TAF3,TGFB2,TGFBR2	
IL-12 Signaling and Production in Macrophages	2.51E00	8.94E-02	1.528	AKT3,IFIH1,JAK2,MAP2K6,MAPK8,NCOA1,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,POU2F1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKDC,STAT3,TGFB2	
Factors involved in megakaryocyte development and platelet production	2.5E00	1.21E-01	3.317	ABL1,AKAP10,DOCK1,DOCK4,DOCK6,DOCK9,JAK2,MFN1,PHF21A,PRKACB,RCOR1	
RHOGDI Signaling	2.5E00	9.09E-02	-2.309	ARHGAP6,ARHGEF11,ARHGEF12,ARHGEF3,CREBBP,DLC1,GNAQ,ITGA1,ITGA6,MYH10,MYH9,MYO10,MYO18A,PI4KA,PIKFYVE,PPP1R12A,RHOBTB1,RHOJ,ROCK1,ROCK2	
WNT/Ca+ pathway	2.49E00	1.36E-01	3.000	ATF2,CREBBP,FZD6,NFAT5,NFKB1,PLCB1,PLCB4,PLCG1,PPP3CA	
Nephrin family interactions	2.45E00	2.17E-01	2.236	CASK,PIK3CA,PIK3R1,SPTAN1,SPTBN1	
Formation of paraxial mesoderm	2.45E00	2.17E-01	2.236	CREBBP,KAT2B,LEF1,MAML3,NOTCH1	
MAPK targets/ Nuclear events mediated by MAP kinases	2.44E00	1.82E-01	2.449	ATF2,DUSP3,MAPK8,MEF2A,MEF2C,RPS6KA3	
SUMOylation of transcription cofactors	2.42E00	1.59E-01	2.646	CREBBP,HIPK2,NCOA1,NCOA2,PHC3,PIAS1,SCMH1	
WNT/SHH Axonal Guidance Signaling Pathway	2.41E00	1.01E-01	1.291	ADCY9,FZD6,ITPR1,ITPR2,LEF1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLXNA2,PRKACB,SEMA3C,TCF4,TCF7L2	
Paxillin Signaling	2.41E00	1.12E-01	3.162	DOCK1,GIT2,ITGA1,ITGA6,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS1,SOS2	
PD-1, PD-L1 cancer immunotherapy pathway	2.41E00	1.12E-01	-2.111	AKT3,BCL2L1,CBLB,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,SMAD3,TGFB2	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	2.4E00	9.28E-02	NaN	BCL2,COL4A2,ECE1,FGFR2,FLT1,FLT4,IGF1R,KDR,LEPR,MYH10,MYH9,MYO10,MYO18A,NFKB1,PDGFD,SMAD3,TGFB2,TGFBR2	
ISGylation Signaling Pathway	2.37E00	1.11E-01	1.155	ARIH1,CCND1,CREBBP,FLNB,IFIH1,JAK1,MAPK8,NFAT5,NFKB1,PRKN,TRIM25,XIAP	
Oncogene Induced Senescence	2.37E00	1.76E-01	-0.816	AGO3,ETS1,RB1,SP1,TNRC6A,TNRC6B	
Interleukin-6 family signaling	2.37E00	2.08E-01	2.236	CBL,JAK1,JAK2,OSMR,STAT3	
S100 Family Signaling Pathway	2.35E00	6.74E-02	6.379	ABCB1,ADGRF5,ADGRL3,ADGRL4,AHNAK,AKT3,APP,ARNT,ATF2,BCL2,BRAF,CACNA1E,CALCRL,CREBBP,DLC1,FGFR2,FZD6,GPR155,ITPR1,ITPR2,JAK1,LEF1,MAP2K5,MAP2K6,MAPK8,MYH9,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,ROCK1,ROCK2,SMAD1,SMAD3,SMAD5,SMAD6,SP1,STAT3,TCF4,TCF7L2,TGFB2,TRAF3	
PI Metabolism	2.35E00	1.22E-01	3.162	INPP5F,MTMR3,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLEKHA5,SBF2	
CD27 Signaling in Lymphocytes	2.35E00	1.4E-01	2.828	BCL2L1,MAP2K5,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFKB1	
Role of IL-17A in Arthritis	2.35E00	1.4E-01	NaN	ATF2,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
DHCR24 Signaling Pathway	2.34E00	1.02E-01	2.673	AKT3,APP,NFKB1,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,VTN	
Î±-Adrenergic Signaling	2.34E00	1.1E-01	3.162	ADCY9,GNAQ,ITPR1,ITPR2,PHKB,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Miro GTPase Cycle	2.33E00	3.75E-01	NaN	MFN1,RAP1GDS1,TRAK2	
HMGB1 Signaling	2.32E00	9.58E-02	3.873	AKT3,KAT2B,KAT6A,Kat6b,MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RHOBTB1,RHOJ,SP1,TGFB2	
Death Receptor Signaling	2.32E00	1.15E-01	1.508	BCL2,CFLAR,MAP4K4,MAPK8,NFKB1,PARP14,ROCK1,SPTAN1,TNKS,TNKS2,XIAP	
Apelin Pancreas Signaling Pathway	2.31E00	1.52E-01	0.378	MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB	
Interleukin-4 and Interleukin-13 signaling	2.31E00	1.09E-01	3.464	BCL2,BCL2L1,CCND1,FOXO1,FOXO3,JAK1,JAK2,PIK3R1,POU2F1,RORA,STAT3,ZEB1	
Transcriptional Regulation by NPAS4	2.3E00	1.71E-01	0.000	AGO3,ARNT,CREBBP,PLK2,TNRC6A,TNRC6B	
D-myo-inositol-5-phosphate Metabolism	2.3E00	9.09E-02	3.606	ATP1A2,INPP5F,PIKFYVE,PLCB1,PLCB4,PLCG1,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	2.27E00	1.27E-01	3.000	EXOC2,EXOC4,EXOC6,LNPEP,MYH9,RALGAPA2,RALGAPB,TBC1D1,TBC1D4	
nNOS Signaling in Neurons	2.26E00	1.49E-01	NaN	PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Ephrin A Signaling	2.26E00	1.49E-01	NaN	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,ROCK1,ROCK2	
Polyamine Regulation in Colon Cancer	2.25E00	1.36E-01	2.121	AKT3,APC,BRAF,MAP2K5,MAP2K6,RPTOR,TCF4,TCF7L2	
D-myo-inositol (1,4,5)-Trisphosphate Biosynthesis	2.21E00	1.92E-01	2.236	PI4KA,PIKFYVE,PLCB1,PLCB4,PLCG1	
MicroRNA Biogenesis Signaling Pathway	2.21E00	9.09E-02	3.638	ABL1,AGO3,AKT3,CSDE1,DICER1,DROSHA,Fus,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KB1,SMAD1,SMAD3,SMAD5,TGFB2,XRN1	
Th1 and Th2 Activation Pathway	2.2E00	9.3E-02	NaN	ACVR2A,BMPR2,CHD4,DLL4,JAK1,JAK2,MAP2K6,NFKB1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3,TGFBR2,TGFBR3	
Fcgamma receptor (FCGR) dependent phagocytosis	2.2E00	9.55E-02	3.606	ABL1,DOCK1,ELMO1,ITPR1,ITPR2,MYH9,MYO10,NCKAP1,NF2,PIK3CA,PIK3R1,PLCG1,PRKCE,PTK2,WIPF1	
Phagosome Formation	2.2E00	6.75E-02	6.856	ADGRF5,ADGRL3,ADGRL4,AKT3,AP1G1,CALCRL,CLIP1,CRKL,DOCK1,ELMO1,FZD6,GAB2,GPR155,ITGA1,ITGA6,ITPR1,ITPR2,MALT1,MAP2K5,MAP2K6,MYH10,MYH9,MYO10,MYO18A,PI4KA,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PIKFYVE,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RAPGEF1,RAPGEF4,ROCK1,ROCK2,RPS6KB1,SAP130,SOS1,SOS2,VTN,WIPF1	
Extra-nuclear estrogen signaling	2.19E00	1.23E-01	3.000	AKT3,BCL2,CCND1,FOXO3,IGF1R,PIK3CA,PIK3R1,PIK3R3,PTK2	
S Phase	2.19E00	1.1E-01	2.111	AKT3,CCND1,LIN52,MNAT1,PDS5A,PDS5B,PSME4,RAD21,RB1,RBL2,STAG1	
ATM Signaling	2.19E00	1.1E-01	1.000	ABL1,ATF2,CBX5,CREBBP,HERC2,MAPK8,PPM1L,PPP2R5E,TLK2,USP7,ZEB1	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	2.17E00	2.35E-01	2.000	IGF1R,PIK3CA,PIK3R1,SOS1	
Signaling by NTRK3 (TRKC)	2.17E00	2.35E-01	2.000	PIK3CA,PIK3R1,PLCG1,SOS1	
FOXO-mediated transcription of cell cycle genes	2.17E00	2.35E-01	2.000	FOXO1,FOXO3,RBL2,SMAD3	
Cilium Assembly	2.17E00	8.82E-02	4.243	ALMS1,ASAP1,BBS9,C2CD3,CEP250,CEP83,CLASP1,CNTRL,DYNC1H1,EXOC2,EXOC4,EXOC6,GBF1,PCM1,PKD2,SCLT1,TNPO1,TRIP11	
Semaphorin Signaling in Neurons	2.17E00	1.31E-01	NaN	ARHGEF12,NRP1,PLXNA2,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2	
Interleukin-1 family signaling	2.16E00	1.01E-01	3.606	BTRC,FBXW11,MAP2K6,MAP3K3,MAPK8,NFKB1,PELI1,PSME4,PTPN14,PTPN4,SMAD3,STAT3,TAB2	
trans-Golgi Network Vesicle Budding	2.16E00	1.22E-01	3.000	AP1G1,AP3B1,APP,GBF1,GOLGB1,PICALM,PIK3C2A,SH3D19,SORT1	
PFKFB4 Signaling Pathway	2.16E00	1.43E-01	2.646	ATF2,CREBBP,MAP2K5,MAP2K6,PRKACB,TGFB2,XDH	
IL-13 Signaling Pathway	2.13E00	1.03E-01	3.464	AKT3,BCL2L1,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,ROCK1,ROCK2,STAT3,TGFB2	
Cytoprotection by HMOX1	2.12E00	1.29E-01	2.828	CHD9,CREBBP,NCOA1,NCOA2,NCOR1,STAT3,TBL1X,TBL1XR1	
Role of JAK2 in Hormone-like Cytokine Signaling	2.12E00	1.29E-01	2.646	BCL2,BCL2L1,CCND1,GHR,JAK1,JAK2,LEPR,STAT3	
Signaling by EGFR	2.11E00	1.4E-01	2.646	CBL,GAB1,PIK3CA,PIK3R1,PLCG1,PTPRK,SOS1	
Signaling by NOTCH3	2.11E00	1.4E-01	2.646	CREBBP,DLL4,KAT2B,MAML3,MIB1,NOTCH1,PBX1	
Pre-NOTCH Expression and Processing	2.08E00	1.18E-01	2.449	AGO3,CCND1,CREBBP,KAT2B,MAML3,NOTCH1,ST3GAL3,TNRC6A,TNRC6B	
SUMOylation of DNA damage response and repair proteins	2.08E00	1.18E-01	3.000	HDAC7,HERC2,NSMCE2,PHC3,PIAS1,RAD21,SCMH1,STAG1,WRN	
Signaling by ALK	2.07E00	1.79E-01	2.236	FRS2,PIK3CA,PIK3R1,PLCG1,STAT3	
MAP kinase activation	2.07E00	1.54E-01	2.449	BTRC,FBXW11,MAP2K6,MAPK8,NFKB1,TAB2	
Apoptosis Signaling	2.06E00	1.06E-01	-1.265	BCL2,BCL2L1,BIRC6,MAP4K4,MAPK8,NFKB1,PLCG1,PRKCE,ROCK1,SPTAN1,XIAP	
UVC-Induced MAPK Signaling	2.06E00	1.37E-01	2.646	BRAF,MAPK8,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	2.06E00	1.37E-01	0.000	ABL1,BTRC,HIPK2,KAT2B,PRKDC,TOP2B,TRIP12	
GÎ±12/13 Signaling	2.06E00	9.77E-02	3.606	AKT3,MAP3K1,MAPK8,MEF2A,MEF2C,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,ROCK1,ROCK2	
MSP-RON Signaling in Macrophages Pathway	2.04E00	1.01E-01	1.897	ATF2,CREBBP,GAB2,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2,STAT3	
Cardiac Î²-adrenergic Signaling	2.02E00	8.89E-02	1.897	ADCY9,AKAP10,AKAP11,AKAP13,AKAP7,CACNA1E,GNAQ,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PPM1L,PPP1R12A,PPP2R5E,PRKACB	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	2.01E00	1.72E-01	2.236	LAMC1,SMARCA4,TEAD1,UTRN,WWTR1	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.97E00	1.14E-01	2.333	BCL2L1,CCND1,JAK1,JAK2,MAPK8,OSMR,PIAS1,STAT3,TGFB2	
Natural Killer Cell Signaling	1.97E00	8.59E-02	4.123	AKT3,JAK2,MAP3K1,MAP3K2,MAP3K3,MICB,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,ROCK1,SOS1,SOS2,WIPF1	
Synaptic Long Term Depression	1.97E00	8.59E-02	3.357	CACNA1E,GNAQ,IGF1R,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PPM1L,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PRKG1,SMARCC2	
Actin Nucleation by ARP-WASP Complex	1.97E00	1.08E-01	1.633	ITGA1,ITGA6,PPP1R12A,RHOBTB1,RHOJ,ROCK1,ROCK2,SOS1,SOS2,WIPF1	
Th2 Pathway	1.95E00	9.49E-02	1.387	ACVR2A,BMPR2,CHD4,JAK1,JAK2,NFKB1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TGFBR2,TGFBR3	
Role of p14/p19ARF in Tumor Suppression	1.94E00	1.67E-01	-1.342	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RB1	
NR1D1 (REV-ERBA) represses gene expression	1.92E00	5E-01	NaN	NCOR1,NR1D1	
Interleukin-12 family signaling	1.91E00	2E-01	2.000	CANX,JAK1,JAK2,STAT3	
Regulation of beta-cell development	1.91E00	1.43E-01	2.449	AKT3,CREBBP,FOXO1,KAT2B,MAML3,NOTCH1	
Acute Phase Response Signaling	1.91E00	8.65E-02	2.000	AKT3,CP,JAK2,MAP2K6,MAP3K1,MAPK8,NFKB1,OSMR,PIK3CA,PIK3R1,PIK3R3,SOCS7,SOS1,SOS2,STAT3,TCF4	
IL-10 Signaling	1.91E00	9.09E-02	1.604	AKT3,ATF2,BCL2,BCL2L1,CCND1,CREBBP,JAK1,MAP2K6,MAP4K4,MAPK8,NFKB1,PBX1,SP1,STAT3	
Signaling by Leptin	1.91E00	2.73E-01	NaN	JAK2,LEPR,STAT3	
Intrinsic Pathway for Apoptosis	1.89E00	1.27E-01	2.646	AKT3,BCL2,BCL2L1,MAPK8,PPP3CC,STAT3,XIAP	
Signaling by PTK6	1.89E00	1.27E-01	2.646	CBL,CCND1,DOCK1,ELMO1,EPAS1,LRRK2,STAT3	
Intra-Golgi and retrograde Golgi-to-ER traffic	1.87E00	8.37E-02	4.123	COG5,DYNC1H1,GALNT1,GBF1,GOLGA4,GOLIM4,KIF13B,KIF16B,KIF1B,MAN1A1,MAN2A1,NBAS,RIC1,TRIP11,USP6NL,VPS54,VTI1A	
Oncostatin M Signaling	1.87E00	1.4E-01	2.236	EPAS1,JAK1,JAK2,OSMR,SOS1,STAT3	
SPINK1 General Cancer Pathway	1.85E00	1.16E-01	2.828	AKT3,JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Salvage Pathways of Pyrimidine Ribonucleotides	1.85E00	1.03E-01	3.162	ACVR2A,BRAF,DYRK1A,GRK5,HIPK1,MAP2K6,MAPK8,PKN1,PRKCE,PRKCH	
RHO GTPases activate PAKs	1.84E00	1.9E-01	2.000	MYH10,MYH9,NF2,PPP1R12A	
ROBO SLIT Signaling Pathway	1.83E00	9.45E-02	0.577	ABL1,AKT3,APP,CTNND1,FLT1,FLT4,KDR,PRKACB,ROBO4,SRGAP1,SRGAP2,TGFBR2	
PI3K Cascade	1.82E00	1.36E-01	2.449	FGFR2,FRS2,GAB1,GAB2,PIK3CA,PIK3R1	
Hepatic Cholestasis	1.8E00	8.07E-02	1.886	ABCB1,ADCY9,AKT3,FOXO1,INSR,MAPK8,NFKB1,PPP3CA,PPP3CC,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SLCO1C1,TGFB2,TJP2	
CREB Signaling in Neurons	1.79E00	6.59E-02	6.083	ADCY9,ADGRF5,ADGRL3,ADGRL4,AKT3,ATF2,BMPR2,CACNA1E,CALCRL,CREBBP,FGFR2,FLT1,FLT4,FZD6,GHR,GNAQ,GPR155,IGF1R,INSR,ITPR1,ITPR2,KDR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,SOS1,SOS2,TGFB2,TGFBR2,TGFBR3	
ISG15 antiviral mechanism	1.78E00	1.13E-01	2.828	ARIH1,EIF4G1,EIF4G3,FLNB,JAK1,PLCG1,PPM1B,TRIM25	
RUNX1 regulates megakaryocyte differentiation and platelet function	1.77E00	1.21E-01	2.646	AGO3,KAT2B,KMT2A,KMT2C,KMT2D,TNRC6A,TNRC6B	
Regulation of Actin-based Motility by Rho	1.75E00	9.57E-02	0.707	ITGA1,ITGA6,MPRIP,PI4KA,PIKFYVE,PPP1R12A,Ppp1r12b,RHOBTB1,RHOJ,ROCK1,WIPF1	
3-phosphoinositide Degradation	1.75E00	8.29E-02	3.317	ATP1A2,INPP5F,MTMR3,PIKFYVE,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
Ephrin B Signaling	1.75E00	1.11E-01	2.646	CBL,CXCL12,GNAQ,ITSN2,KALRN,PTK2,ROCK1,ROCK2	
Signaling by ERBB4	1.73E00	1.19E-01	2.236	CXCL12,NCOR1,PIK3CA,PIK3R1,SOS1,TAB2,WWOX	
Inhibition of Angiogenesis by TSP1	1.72E00	1.47E-01	2.000	AKT3,HSPG2,KDR,MAPK8,TGFBR2	
Glioma Invasiveness Signaling	1.71E00	1.1E-01	2.646	PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,RHOBTB1,RHOJ,VTN	
PAK Signaling	1.7E00	9.4E-02	3.000	ITGA1,ITGA6,MAPK8,PDGFD,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PTK2,SOS1,SOS2	
Endocannabinoid Neuronal Synapse Pathway	1.68E00	8.72E-02	2.111	ADCY9,CACNA1E,DNAH3,GNAQ,ITPR1,ITPR2,MAPK8,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKACB	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	1.65E00	8.24E-02	3.162	ATP1A2,INPP5F,PIKFYVE,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	1.65E00	8.24E-02	3.162	ATP1A2,INPP5F,PIKFYVE,PPIP5K1,PPM1H,PPM1K,PPM1L,PPP1R12A,PPP1R16B,PPP2R5E,PPP3CA,PPP3CC,PTPRM,RNGTT,SSH2	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	1.65E00	1.07E-01	0.000	ADCY9,GNAQ,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PRKACB	
Regulation of RUNX1 Expression and Activity	1.64E00	1.67E-01	NaN	AGO3,CCND1,TNRC6A,TNRC6B	
IL-22 Signaling	1.64E00	1.67E-01	2.000	AKT3,JAK1,MAPK8,STAT3	
NAD Signaling Pathway	1.63E00	8.61E-02	3.051	AKT3,CLOCK,GJA1,HMGCS2,NFKB1,PARP14,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TGFB2,TNKS,TNKS2	
p38 MAPK Signaling	1.63E00	9.17E-02	2.828	ATF2,CREBBP,MAP2K6,MEF2A,MEF2C,RPS6KA3,RPS6KB1,RPS6KC1,TAB2,TGFB2,TGFBR2	
Role of PKR in Interferon Induction and Antiviral Response	1.62E00	8.82E-02	2.887	ATF2,FANCC,IFIH1,JAK1,MAP2K6,MAPK8,NFKB1,PDGFD,SP1,STAT3,TAB2,TRAF3	
Interferon Signaling	1.62E00	1.39E-01	0.000	BCL2,JAK1,JAK2,MED14,PIAS1	
Regulation of eIF4 and p70S6K Signaling	1.62E00	8.15E-02	2.333	AGO3,AKT3,EIF4G1,EIF4G3,ITGA1,ITGA6,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPM1L,PPP2R5E,RPS6KB1,SOS1,SOS2	
Extracellular matrix organization	1.6E00	9.43E-02	3.162	APP,COL4A2,HSPG2,ITGA1,ITGA6,LAMA4,LAMC1,NID1,TGFB2,VTN	
IL-33 Signaling Pathway	1.6E00	8.11E-02	3.873	AKT3,ATF2,BCL2L1,CREBBP,JAK2,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,RPS6KB1,RPS6KC1,STAT3	
CDX Gastrointestinal Cancer Signaling Pathway	1.59E00	7.92E-02	-1.500	AKT3,BRAF,CCND1,FZD6,JAK1,JAK2,LEF1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3,TCF4,TCF7L2,TGFB2	
Th1 Pathway	1.58E00	9.02E-02	3.317	DLL4,JAK1,JAK2,MAP2K6,NFKB1,NOTCH1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
cAMP-mediated signaling	1.58E00	7.63E-02	3.742	ADCY9,AKAP10,AKAP11,AKAP13,AKAP7,ATF2,BRAF,CREBBP,PDE10A,PDE4B,PDE5A,PDE7B,PDE8A,PPP3CA,PPP3CC,PRKACB,RAPGEF4,STAT3	
ABRA Signaling Pathway	1.58E00	9.78E-02	3.000	MAPK8,MEF2A,MEF2C,MYH9,PPP3CA,PPP3CC,ROCK1,ROCK2,SVIL	
MAPK6/MAPK4 signaling	1.58E00	9.78E-02	0.707	AGO3,CDC14A,FOXO1,FOXO3,KALRN,PRKACB,PSME4,TNRC6A,TNRC6B	
Insulin processing	1.58E00	1.6E-01	2.000	EXOC2,EXOC4,EXOC6,MYRIP	
White Adipose Tissue Browning Pathway	1.58E00	8.7E-02	3.000	ADCY9,ATF2,CACNA1E,CREBBP,FGFR2,ITPR1,ITPR2,KDR,NRF1,PRKACB,PRKG1,SLC16A1	
MYC Mediated Apoptosis Signaling	1.57E00	1.2E-01	-0.816	BCL2,BCL2L1,CFLAR,CREBBP,NFKB1,PRKACB	
NRF2-mediated Oxidative Stress Response	1.56E00	7.59E-02	3.317	ABCC4,CREBBP,CUL3,DNAJC1,DNAJC13,MAP2K5,MAP2K6,MAP3K1,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	1.56E00	1.03E-01	NaN	APC,CSNK1G1,FZD6,LEF1,NCOA1,NCOA2,TCF4,TCF7L2	
RHO GTPases Activate Formins	1.55E00	8.63E-02	3.464	CLASP1,CLASP2,CLIP1,DAAM1,DYNC1H1,EVL,FMNL2,MAD1L1,PPP2R5E,SCAI,SRGAP2,TAOK1	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	1.53E00	8.33E-02	3.464	IFIH1,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,TGFB2	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	1.53E00	1.01E-01	2.828	APP,CREBBP,IFIH1,MAP3K1,NFKB1,RNF216,TRAF3,TRIM25	
PXR/RXR Activation	1.52E00	1.08E-01	1.134	ABCB1,AKT3,FOXO1,HMGCS2,INSR,NCOA1,PRKACB	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	1.52E00	1.54E-01	NaN	JAK1,JAK2,NFKB1,STAT3	
Fc epsilon receptor (FCERI) signaling	1.52E00	7.77E-02	3.742	BTRC,FBXW11,GAB2,ITPR1,ITPR2,MALT1,MAP3K1,MAPK8,NFKB1,PIK3CA,PIK3R1,PLCG1,PPP3CA,PSME4,SOS1,TAB2	
Mitochondrial Dysfunction	1.52E00	6.98E-02	0.816	APP,ATF2,ATP1A2,BCL2,CACNA1E,CREBBP,CYB5B,FBXW7,HTT,ITPR1,ITPR2,LRRK2,MAPK8,MCU,MFN1,NRF1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKACB,PRKN	
Macrophage Alternative Activation Signaling Pathway	1.51E00	7.89E-02	3.357	ATF2,CREBBP,EPAS1,JAK1,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KB1,RPS6KC1,RPTOR,STAT3,TGFB2	
Apoptotic execution phase	1.49E00	1.15E-01	2.449	APC,PTK2,ROCK1,SPTAN1,TJP1,TJP2	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	1.49E00	1.06E-01	2.449	AKT3,CRKL,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
Aryl Hydrocarbon Receptor Signaling	1.47E00	8.18E-02	0.832	ARNT,CCND1,MAPK8,NCOA2,NFIA,NFIB,NFKB1,RB1,RBL2,SMARCA4,SP1,TGFB2,TRIP11	
Prolactin receptor signaling	1.45E00	1.88E-01	NaN	BTRC,GHR,JAK2	
Rap1 signalling	1.45E00	1.88E-01	NaN	PRKACB,PRKG1,RAPGEF4	
SUMOylation of DNA methylation proteins	1.45E00	1.88E-01	NaN	DNMT3A,PHC3,SCMH1	
FOXO-mediated transcription of cell death genes	1.45E00	1.88E-01	NaN	CREBBP,FOXO1,FOXO3	
IL-27 Signaling Pathway	1.45E00	8.59E-02	2.111	AKT3,JAK1,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RORA,SMAD3,STAT3	
Protein Sorting Signaling Pathway	1.43E00	7.87E-02	3.742	ADCY9,AP1G1,AP3B1,ARFGEF1,GNAQ,GOLGA4,MIA3,PRKACB,PRKD1,SNX13,SNX25,SNX27,SNX29,SORT1	
Signaling by NOTCH4	1.42E00	9.64E-02	2.828	CREBBP,DLL4,FBXW7,FLT4,KAT2B,MAML3,NOTCH1,SMAD3	
Phosphatidylcholine Biosynthesis I	1.42E00	2.86E-01	NaN	CHKA,PHKA1	
SUMOylation of intracellular receptors	1.41E00	1.43E-01	2.000	HDAC4,NR3C2,PIAS1,RORA	
RHO GTPases activate PKNs	1.41E00	1.43E-01	2.000	MYH10,MYH9,PKN1,PPP1R12A	
Clathrin-mediated endocytosis	1.41E00	8.46E-02	3.317	AAK1,CBL,DAB2,DNM3,EPN2,FCHO2,GAPVD1,HIP1,ITSN2,PICALM,PIK3C2A	
Mechanisms of Viral Exit from Host Cells	1.4E00	1.22E-01	NaN	PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	1.4E00	1.01E-01	NaN	JAK1,JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,STAT3	
Deadenylation-dependent mRNA decay	1.39E00	1.09E-01	2.449	CNOT1,CNOT4,CNOT6L,EIF4G1,PAN3,XRN1	
Transcriptional regulation of pluripotent stem cells	1.38E00	1.76E-01	NaN	EPAS1,PBX1,STAT3	
Germ layer formation at gastrulation	1.38E00	1.76E-01	NaN	LEF1,SMAD3,TRIM33	
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	1.38E00	1.76E-01	NaN	INPP5A,INPP5F,ITPKB	
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	1.38E00	1.76E-01	NaN	INPP5A,INPP5F,ITPKB	
Breast Cancer Regulation by Stathmin1	1.38E00	6.23E-02	4.768	ADGRF5,ADGRL3,ADGRL4,ANKHD1/ANKHD1-EIF4EBP3,ARHGEF11,ARHGEF12,ARHGEF3,ATF2,CALCRL,CCND1,CREBBP,FZD6,GNAQ,GPR155,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PPM1L,PPP1R12A,PPP2R5E,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RB1CC1,RPS6KA3,RPS6KB1,SOS1,SOS2,STAT3,TGFB2	
Neurovascular Coupling Signaling Pathway	1.38E00	7.33E-02	1.698	APP,CACNA1E,GJA1,GNAQ,ITPR1,ITPR2,MPRIP,PLCB1,PLCB4,PPP1R12A,Ppp1r12b,PRKACB,PRKG1,ROCK1,ROCK2,SLC16A1,SMARCC2	
Amyotrophic Lateral Sclerosis Signaling	1.37E00	8.62E-02	0.000	AKT3,BCL2,BCL2L1,CACNA1E,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,XIAP	
Processing of Capped Intronless Pre-mRNA	1.37E00	1.38E-01	2.000	CPSF6,CSTF3,PAPOLA,WDR33	
April Mediated Signaling	1.36E00	1.19E-01	2.236	MAP3K1,MAPK8,NFAT5,NFKB1,TRAF3	
NLR signaling pathways	1.36E00	1.07E-01	2.449	APP,BCL2,BCL2L1,MAP2K6,NFKB1,TAB2	
Folate Signaling Pathway	1.36E00	1.07E-01	2.449	BCL2,JAK1,JAK2,MTR,NFKB1,STAT3	
Oxidative Stress Induced Senescence	1.34E00	9.3E-02	2.236	AGO3,MAP2K6,MAP4K4,MAPK8,PHC3,SCMH1,TNRC6A,TNRC6B	
Platelet homeostasis	1.34E00	9.3E-02	2.828	ITPR1,ITPR2,LRP8,PDE10A,PDE5A,PECAM1,PPP2R5E,PRKG1	
Adrenergic Receptor Signaling Pathway (Enhanced)	1.34E00	7.5E-02	3.357	ADCY9,CACNA1E,GNAQ,ITPR1,ITPR2,PLCB1,PLCB4,PLCG1,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,TGFB2	
Wound Healing Signaling Pathway	1.34E00	7.14E-02	3.300	ACVR2A,BMPR2,COL4A2,FGFR2,ITGA6,JAK1,JAK2,LAMC1,MAP2K5,MAP2K6,MAPK8,NFKB1,PDGFD,SOS1,SOS2,TGFB2,TGFBR2,TGFBR3	
Thiamin Salvage III	1.33E00	1E00	NaN	TPK1	
B Cell Activating Factor Signaling	1.33E00	1.16E-01	2.236	MAP3K1,MAPK8,NFAT5,NFKB1,TRAF3	
Regulation of TP53 Activity through Acetylation	1.32E00	1.33E-01	2.000	AKT3,CHD4,KAT6A,MAP2K6	
Signaling by CSF3 (G-CSF)	1.32E00	1.33E-01	2.000	GAB2,JAK1,JAK2,STAT3	
Integration of energy metabolism	1.31E00	8.74E-02	2.646	ACSL3,ADCY9,CACNA1E,GNAQ,ITPR1,ITPR2,PLCB1,PRKACB,RAPGEF4	
DNA Damage Reversal	1.3E00	2.5E-01	NaN	ASCC3,FTO	
Inositol Pyrophosphates Biosynthesis	1.3E00	2.5E-01	NaN	IP6K1,PPIP5K1	
BER (Base Excision Repair) Pathway	1.29E00	1.14E-01	1.342	HUWE1,MAP2K5,MAP2K6,NF1,SP1	
Metabolism of water-soluble vitamins and cofactors	1.26E00	1.02E-01	2.449	ACACA,ACACB,HLCS,MTR,PCCA,TPK1	
DNA Double Strand Break Response	1.26E00	1.02E-01	2.449	ABL1,BABAM2,BAZ1B,EYA3,HERC2,MAPK8	
RHO GTPases activate CIT	1.26E00	1.58E-01	NaN	MYH10,MYH9,PPP1R12A	
Iron homeostasis signaling pathway	1.26E00	7.97E-02	NaN	ARNT,BMPR2,BTRC,CP,EPAS1,JAK1,JAK2,SMAD1,SMAD3,SMAD5,STAT3	
PCP (Planar Cell Polarity) Pathway	1.23E00	1E-01	2.449	ATF2,DAAM1,FZD6,MAPK8,ROCK1,ROCK2	
RIPK1-mediated regulated necrosis	1.23E00	1.25E-01	2.000	CFLAR,PELI1,PRKN,XIAP	
TNFR2 Signaling	1.23E00	1.25E-01	1.000	MAP3K1,MAPK8,NFKB1,XIAP	
PPAR Signaling	1.22E00	8.41E-02	-1.667	CREBBP,INSR,MAP4K4,NCOA1,NCOR1,NFKB1,PDGFD,SOS1,SOS2	
Role of RIG1-like Receptors in Antiviral Innate Immunity	1.22E00	1.09E-01	2.000	CREBBP,IFIH1,NFKB1,TRAF3,TRIM25	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	1.22E00	1.09E-01	NaN	JARID2,MEF2A,PHC3,RB1,TASOR	
tRNA Splicing	1.22E00	1.09E-01	2.236	PDE10A,PDE4B,PDE5A,PDE7B,PDE8A	
Interleukin-9 signaling	1.21E00	2.22E-01	NaN	JAK1,STAT3	
Phosphatidylethanolamine Biosynthesis II	1.21E00	2.22E-01	NaN	CHKA,ETNK1	
NCAM signaling for neurite out-growth	1.21E00	9.84E-02	2.449	COL4A2,PTK2,PTPRA,SOS1,SPTAN1,SPTBN1	
Degradation of beta-catenin by the destruction complex	1.2E00	8.7E-02	1.633	APC,BTRC,LEF1,PPP2R5E,PSME4,TCF4,TCF7L2,TLE1	
L1CAM interactions	1.19E00	8E-02	3.162	DLG1,DNM3,ITGA1,LAMC1,NRP1,NUMB,RANBP9,RPS6KA3,SPTAN1,SPTBN1	
Neddylation	1.18E00	6.91E-02	3.638	BTRC,COMMD10,COP1,CUL3,DCAF5,DCAF6,EPAS1,FBXL7,FBXO11,FBXW11,FBXW7,KLHL2,KLHL3,LMO7,PSME4,PUM2,TULP4	
UFMylation Signaling Pathway	1.18E00	9.68E-02	0.816	AKT3,CCND1,EIF4G1,EIF4G3,NCOA1,NFKB1	
TCR signaling	1.17E00	7.94E-02	3.162	BTRC,EVL,FBXW11,MALT1,NFKB1,PIK3CA,PIK3R1,PLCG1,PSME4,TAB2	
EIF2 Signaling	1.16E00	6.96E-02	3.606	AGO3,AKT3,BCL2,CCND1,EIF2AK4,EIF4G1,EIF4G3,IGF1R,INSR,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2,XIAP	
Gap junction trafficking and regulation	1.15E00	1.18E-01	2.000	DAB2,GJA1,MYO6,TJP1	
Transcriptional Regulation by E2F6	1.15E00	1.18E-01	NaN	CBX5,EHMT1,MGA,PHC3	
C-type lectin receptors (CLRs)	1.13E00	7.59E-02	3.317	BTRC,CREBBP,FBXW11,ITPR1,ITPR2,MALT1,NFKB1,PPP3CA,PRKACB,PSME4,TAB2	
TP53 Regulates Transcription of Cell Cycle Genes	1.12E00	1.02E-01	2.236	CNOT1,CNOT4,CNOT6L,PLK2,RBL2	
IL-1 Signaling	1.12E00	8.33E-02	2.449	ADCY9,GNAQ,MAP2K6,MAP3K1,MAPK8,NFKB1,PRKACB,TAB2	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	1.1E00	1.36E-01	NaN	INPP5A,INPP5F,ITPKB	
Activation of IRF by Cytosolic Pattern Recognition Receptors	1.1E00	9.23E-02	1.633	ATF2,CREBBP,IFIH1,MAPK8,NFKB1,TRAF3	
RHO GTPases Activate WASPs and WAVEs	1.08E00	1.11E-01	2.000	ABL1,NCKAP1,PTK2,WIPF1	
Sleep NREM Signaling Pathway	1.07E00	7.83E-02	-2.333	ADCY9,ATF2,BRAF,CREBBP,HDAC4,MAP2K5,MAP2K6,PRKACB,SIK3	
CDK5 Signaling	1.07E00	7.83E-02	1.134	ABL1,ADCY9,ITGA6,LAMC1,MAPK8,PPM1L,PPP1R12A,PPP2R5E,PRKACB	
Signaling by NODAL	1.06E00	1.3E-01	NaN	ACVR2A,FOXO3,SMAD3	
Vitamin-C Transport	1.06E00	1.3E-01	NaN	LRRC8C,LRRC8D,NXN	
Bladder Cancer Signaling	1.05E00	7.76E-02	NaN	ABL1,CCND1,FGF13,HDAC4,HDAC7,HDAC8,HDAC9,RB1,RBL2	
Alpha-protein kinase 1 signaling pathway	1.05E00	1.82E-01	NaN	ALPK1,TAB2	
All-trans-decaprenyl Diphosphate Biosynthesis	1.04E00	5E-01	NaN	PDSS2	
GDP-L-fucose Biosynthesis I (from GDP-D-mannose)	1.04E00	5E-01	NaN	GMDS	
Glutamine Degradation I	1.04E00	5E-01	NaN	GLS	
IL-17 Signaling	1.03E00	6.95E-02	3.606	AKT3,ATF2,JAK1,JAK2,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,TAB2,TGFB2	
Signaling by the B Cell Receptor (BCR)	1.02E00	7.06E-02	3.162	BTRC,FBXW11,ITPR1,ITPR2,MALT1,NFKB1,PIK3R1,PPP3CA,PRKCB,PSME4,RASGRP3,SOS1	
Glycogen metabolism	1.01E00	1.25E-01	NaN	GBE1,PHKA1,PHKB	
Growth hormone receptor signaling	1.01E00	1.25E-01	NaN	GHR,JAK2,STAT3	
Cell Cycle Regulation by BTG Family Proteins	1.01E00	1.05E-01	NaN	CCND1,PPM1L,PPP2R5E,RB1	
Notch Signaling	1.01E00	1.05E-01	NaN	DLL4,MAML3,NOTCH1,NUMB	
Integrin cell surface interactions	1.01E00	8.24E-02	2.646	COL4A2,HSPG2,ITGA1,ITGA6,KDR,PECAM1,VTN	
Regulation of TP53 Expression and Degradation	9.81E-01	1.03E-01	2.000	AKT3,PHF20,RICTOR,USP7	
Superpathway of Methionine Degradation	9.81E-01	1.03E-01	2.000	AHCYL2,EHMT1,MTR,PCCA	
TP53 Regulates Transcription of DNA Repair Genes	9.8E-01	8.57E-02	2.449	AP1G1,ATF2,CDK12,CDK13,FANCC,MNAT1	
MyD88 cascade initiated on plasma membrane	9.71E-01	1.2E-01	NaN	MAP3K1,PELI1,TAB2	
IL-17A Signaling in Fibroblasts	9.67E-01	8.05E-02	2.646	BCL2,CXCL12,JAK2,MAPK8,NFKB1,PRKCB,STAT3	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	9.67E-01	8.05E-02	1.000	APC,FZD6,LEF1,NFKB1,NOTCH1,TCF4,TCF7L2	
Neurotransmitter release cycle	9.5E-01	1E-01	2.000	CASK,GLS,SLC1A1,UNC13B	
TP53 Regulates Metabolic Genes	9.48E-01	7.95E-02	0.378	AGO3,AKT3,GLS,RPTOR,SESN3,TNRC6A,TNRC6B	
CSDE1 Signaling Pathway	9.35E-01	8.93E-02	2.000	AGO3,AKT3,CSDE1,HNRNPC,TRIO	
SUMOylation of chromatin organization proteins	9.35E-01	8.93E-02	2.236	CBX5,HDAC4,PHC3,PIAS1,SCMH1	
Xenobiotic Metabolism CAR Signaling Pathway	9.34E-01	6.7E-02	-0.277	ABCB1,CHST11,CREBBP,MAP2K5,MAP2K6,NCOA1,PPM1L,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Miscellaneous transport and binding events	9.33E-01	1.15E-01	NaN	ADD3,LRRC8C,LRRC8D	
Interleukin-20 family signaling	9.33E-01	1.15E-01	NaN	JAK1,JAK2,STAT3	
Azathioprine ADME	9.24E-01	1.54E-01	NaN	ABCC4,XDH	
RNA Polymerase III Transcription	9.21E-01	9.76E-02	2.000	NFIA,NFIB,POU2F1,SNAPC3	
Neurexins and neuroligins	9.11E-01	8.77E-02	2.236	CASK,EPB41,EPB41L2,SHANK3,SIPA1L1	
TNF signaling	9.11E-01	8.77E-02	2.236	CFLAR,OTUD7B,SPPL2A,TAB2,XIAP	
Syndecan interactions	8.96E-01	1.11E-01	NaN	CASK,ITGA6,VTN	
Integrin signaling	8.96E-01	1.11E-01	NaN	PTK2,RAPGEF4,SOS1	
DAP12 interactions	8.92E-01	9.52E-02	2.000	PIK3CA,PIK3R1,PLCG1,SOS1	
MSP-RON Signaling Pathway	8.87E-01	8.62E-02	NaN	JAK2,PIK3C2A,PIK3CA,PIK3R1,PIK3R3	
GÎ±s Signaling	8.86E-01	7.14E-02	2.121	ADCY9,ADD3,ATF2,BRAF,CREBBP,GNAQ,PRKACB,RAPGEF2,RAPGEF4	
Regulation of NFE2L2 gene expression	8.78E-01	3.33E-01	NaN	NOTCH1	
Caveolar-mediated Endocytosis Signaling	8.75E-01	8E-02	NaN	ABL1,FLNB,INSR,ITGA1,ITGA6,MAP3K2	
Mitotic G2-G2/M phases	8.74E-01	6.53E-02	3.606	ALMS1,BTRC,CEP250,CLASP1,CNTRL,DYNC1H1,FBXL7,FBXW11,LIN52,MNAT1,PCM1,PPP1R12A,PSME4	
Carnitine metabolism	8.7E-01	1.43E-01	NaN	ACACA,ACACB	
Regulation of TP53 Activity through Association with Co-factors	8.7E-01	1.43E-01	NaN	AKT3,PHF20	
Aspirin ADME	8.7E-01	1.43E-01	NaN	SLC16A1,SLCO2B1	
Formation of axial mesoderm	8.7E-01	1.43E-01	NaN	LEF1,SMAD3	
DNA Double-Strand Break Repair by Homologous Recombination	8.7E-01	1.43E-01	NaN	ABL1,ATRX	
DNA Double-Strand Break Repair by Non-Homologous End Joining	8.7E-01	1.43E-01	NaN	PRKDC,WRN	
Signaling by Insulin receptor	8.65E-01	9.3E-02	2.000	INSR,PIK3CA,PIK3R1,SOS1	
Smooth Muscle Contraction	8.65E-01	9.3E-02	2.000	DYSF,ITGA1,PDE5A,SORBS1	
MTOR signalling	8.61E-01	1.07E-01	NaN	EIF4G1,RPS6KB1,RPTOR	
Activated PKN1 stimulates transcription of AR regulated genes KLK2 and KLK3	8.61E-01	1.07E-01	NaN	KDM4C,NCOA2,PKN1	
O-linked glycosylation	8.46E-01	7.21E-02	2.828	ADAMTS9,GALNT1,GALNT15,GALNT18,LARGE1,ST3GAL3,ST6GAL1,ST6GALNAC3	
EPH-Ephrin signaling	8.39E-01	7.45E-02	2.646	KALRN,MYH10,MYH9,PTK2,ROCK1,ROCK2,TIAM1	
TAK1-dependent IKK and NF-kappa-B activation	8.39E-01	9.09E-02	2.000	ALPK1,APP,NFKB1,TAB2	
Antiproliferative Role of Somatostatin Receptor 2	8.37E-01	7.79E-02	2.236	BRAF,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SMARCC2	
Cardiac conduction	8.28E-01	6.92E-02	2.646	ATP1A2,FGF13,HIPK1,HIPK2,ITPR1,ITPR2,KAT2B,KCNQ1,WWTR1	
Signaling by Activin	8.21E-01	1.33E-01	NaN	ACVR2A,SMAD3	
Telomere Extension by Telomerase	8.21E-01	1.33E-01	NaN	TNKS,TNKS2	
Costimulation by the CD28 family	8.18E-01	7.69E-02	2.449	AKT3,PIK3CA,PIK3R1,PIK3R3,PPP2R5E,RICTOR	
Toll-like Receptor Signaling	8.18E-01	7.69E-02	2.000	MAP2K6,MAP3K1,MAP4K4,MAPK8,NFKB1,TAB2	
RNA Polymerase II Transcription	8.15E-01	6.71E-02	3.162	AFF4,CPSF6,CSTF3,MLLT3,MNAT1,PAPOLA,RNGTT,TAF3,THOC2,WDR33	
Mitotic G1 phase and G1/S transition	8.14E-01	6.87E-02	2.121	ABL1,AKT3,CCND1,DYRK1A,JAK2,LIN52,MNAT1,RB1,RBL2	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	8E-01	7.59E-02	2.449	ATF2,BRAF,MAP2K6,MAPK8,NFKB1,RPS6KA3	
Protein ubiquitination	7.96E-01	1E-01	NaN	UBE2H,USP7,USP9X	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	7.96E-01	1E-01	NaN	FOXO1,FOXO3,SMAD3	
Cytosolic sensors of pathogen-associated DNA	7.89E-01	8.7E-02	2.000	CREBBP,NFKB1,PRKDC,TRIM56	
DNA damage-induced 14-3-3Ï Signaling	7.89E-01	8.7E-02	-2.000	AKT3,BCL2,BCL2L1,COP1	
Granzyme B Signaling	7.76E-01	1.25E-01	NaN	NUMA1,PRKDC	
D-myo-inositol (1,4,5)-trisphosphate Degradation	7.76E-01	1.25E-01	NaN	INPP5A,INPP5F	
Parkinson's Signaling	7.76E-01	1.25E-01	NaN	MAPK8,PRKN	
Neutrophil Extracellular Trap Signaling Pathway	7.76E-01	5.75E-02	4.379	AKT3,COL4A2,DOCK1,ITPR1,ITPR2,MAP2K5,MAP2K6,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
MyD88 dependent cascade initiated on endosome	7.66E-01	9.68E-02	NaN	MAP3K1,PELI1,TAB2	
Role of IL-17F in Allergic Inflammatory Airway Diseases	7.66E-01	8.51E-02	2.000	ATF2,CREBBP,NFKB1,RPS6KA3	
iNOS Signaling	7.66E-01	8.51E-02	2.000	CREBBP,JAK1,JAK2,NFKB1	
Activation of anterior HOX genes in hindbrain during early embryogenesis	7.65E-01	7.41E-02	2.449	CREBBP,KDM6A,KMT2C,KMT2D,NCOR1,PBX1	
Methylmalonyl Pathway	7.63E-01	2.5E-01	NaN	PCCA	
Methionine Salvage II (Mammalian)	7.63E-01	2.5E-01	NaN	MTR	
SNARE Signaling Pathway	7.47E-01	6.62E-02	3.000	ADCY9,MYH10,MYH9,MYO10,MYO18A,PRKACB,STXBP5,STXBP6,VTI1A	
G alpha (z) signalling events	7.43E-01	8.33E-02	2.000	ADCY9,PRKCB,PRKCE,PRKCH	
Macroautophagy	7.41E-01	7.69E-02	2.236	AMBRA1,ATG10,RB1CC1,RPTOR,UVRAG	
Induction of Apoptosis by HIV1	7.41E-01	7.69E-02	-0.447	BCL2,BCL2L1,MAPK8,NFKB1,XIAP	
Necroptosis Signaling Pathway	7.4E-01	6.45E-02	3.162	CFLAR,JAK1,MERTK,PELI1,PPP3CA,PPP3CC,RB1,RBL2,TAB2,TRPM7	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	7.38E-01	9.38E-02	NaN	DLG1,MYO6,PRKCB	
G alpha (q) signalling events	7.36E-01	6.32E-02	3.317	APP,GNAQ,GRK5,KALRN,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,RGS5,TRIO	
Xenobiotic Metabolism PXR Signaling Pathway	7.13E-01	6.15E-02	0.000	ABCB1,CHST11,CREBBP,NCOA1,NCOR1,PPP1R12A,PRKACB,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Mitotic Roles of Polo-Like Kinase	7.04E-01	7.46E-02	NaN	PLK2,PPM1L,PPP2R5E,RAD21,SLK	
Mitotic Metaphase and Anaphase	6.96E-01	5.96E-02	3.742	CLASP1,CLASP2,CLIP1,DYNC1H1,HDAC8,MAD1L1,PDS5A,PDS5B,PPP2R5E,PSME4,RAD21,STAG1,TAOK1,TNPO1	
Gastrin-CREB signalling pathway via PKC and MAPK	6.96E-01	1.11E-01	NaN	RPS6KA3,SOS1	
Formation of definitive endoderm	6.96E-01	1.11E-01	NaN	SMAD3,TCF7L2	
Remodeling of Epithelial Adherens Junctions	6.86E-01	7.35E-02	NaN	APC,CLIP1,CTNND1,DNM3,EXOC2	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	6.85E-01	6.38E-02	2.333	CFLAR,CXCL12,FOXO3,JAK2,NFKB1,PPP3CA,PPP3CC,RPTOR,STAT3	
Signaling by NOTCH2	6.84E-01	8.82E-02	NaN	DLL4,MAML3,MIB1	
4-1BB Signaling in T Lymphocytes	6.84E-01	8.82E-02	NaN	ATF2,MAPK8,NFKB1	
Hedgehog 'on' state	6.83E-01	6.98E-02	2.449	CUL3,NUMB,PSME4,SMURF1,SMURF2,SPOPL	
Transcriptional regulation of granulopoiesis	6.79E-01	7.84E-02	NaN	FLI1,KMT2A,LEF1,STAT3	
TNFR1 Signaling	6.79E-01	7.84E-02	1.000	MAP3K1,MAPK8,NFKB1,XIAP	
Amyloid Processing	6.79E-01	7.84E-02	NaN	AKT3,APP,PRKACB,PRKCE	
Choline catabolism	6.76E-01	2E-01	NaN	SLC44A1	
Creatine-phosphate Biosynthesis	6.76E-01	2E-01	NaN	MAP4K4	
Myo-inositol Biosynthesis	6.76E-01	2E-01	NaN	INPP5F	
2-oxobutanoate Degradation I	6.76E-01	2E-01	NaN	PCCA	
Sphingolipid metabolism	6.68E-01	6.9E-02	2.449	ARSB,ESYT2,PPM1L,PRKD1,PRKD3,SGMS1	
Xenobiotic Metabolism AHR Signaling Pathway	6.68E-01	6.9E-02	1.633	ARNT,CREBBP,HDAC4,NCOA1,NCOA2,NFKB1	
Regulation of TP53 Activity through Methylation	6.6E-01	1.05E-01	NaN	EHMT1,JMY	
GPVI-mediated activation cascade	6.59E-01	8.57E-02	NaN	PIK3CA,PIK3R1,PIK3R3	
Inhibition of ARE-Mediated mRNA Degradation Pathway	6.51E-01	6.13E-02	-0.632	AGO3,AKT3,CNOT1,CNOT4,PAPOLA,PPM1L,PPP2R5E,PRKACB,PSME4,XRN1	
Cargo recognition for clathrin-mediated endocytosis	6.45E-01	6.54E-02	2.646	AAK1,CBL,DAB2,EPN2,FCHO2,ITSN2,PICALM	
Inflammasome pathway	6.27E-01	1E-01	NaN	NEK7,NFKB1	
Unfolded protein response	6.25E-01	6.67E-02	1.000	ATF6,BCL2,CANX,DNAJC1,DNAJC13,MAPK8	
Basal Cell Carcinoma Signaling	6.2E-01	6.94E-02	2.236	APC,FZD6,LEF1,TCF4,TCF7L2	
TWEAK Signaling	6.13E-01	8.11E-02	NaN	NFKB1,TRAF3,XIAP	
KEAP1-NFE2L2 pathway	6.11E-01	6.59E-02	2.449	AKT3,BTRC,CREBBP,CUL3,FBXL17,PSME4	
Kinetochore Metaphase Signaling Pathway	6.07E-01	6.36E-02	0.000	DNAH3,MAD1L1,PPP1R12A,Ppp2r5c,PPP2R5E,RAD21,STAG1	
Chondroitin and Dermatan Biosynthesis	6.07E-01	1.67E-01	NaN	CSGALNACT1	
Senescence-Associated Secretory Phenotype (SASP)	6.05E-01	6.85E-02	2.236	EHMT1,IGFBP7,NFKB1,RPS6KA3,STAT3	
Amyloid fiber formation	6.05E-01	6.85E-02	2.236	APP,HSPG2,PRKN,TSPAN5,USP9X	
Meiotic synapsis	6.03E-01	7.27E-02	2.000	RAD21,STAG1,SYNE1,SYNE2	
Sensory processing of sound by outer hair cells of the cochlea	6.03E-01	7.27E-02	2.000	CASK,MYH9,SPTAN1,SPTBN1	
Cell junction organization	5.97E-01	6.52E-02	2.449	AFDN,CADM1,CTNND1,ITGA6,LIMS1,PARD3	
Endoplasmic Reticulum Stress Pathway	5.96E-01	9.52E-02	NaN	ATF6,MAPK8	
Sleep REM Signaling Pathway	5.95E-01	6.31E-02	1.890	ATF2,CREBBP,PRKACB,RPS6KA3,RPS6KB1,RPS6KC1,TGFB2	
Cell Cycle Control of Chromosomal Replication	5.86E-01	7.14E-02	2.000	CDK12,CDK13,CDK19,TOP2B	
Ferroptosis Signaling Pathway	5.84E-01	6.11E-02	0.707	ACACA,BRAF,RB1,RBL2,SP1,STAT3,USP7,WWTR1	
NF-ÎºB Signaling	5.83E-01	5.25E-02	5.477	AKT3,BMPR2,BRAF,BTRC,CREBBP,FGFR2,FLT1,FLT4,GHR,IGF1R,INSR,KDR,MALT1,MAP2K6,MAP3K1,MAP3K3,MAP4K4,MAPK8,NFKB1,PELI1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PRKACB,PRKCB,TAB2,TGFBR2,TGFBR3,TRAF3	
Pyroptosis Signaling Pathway	5.71E-01	6.38E-02	0.816	FOXO3,KCNQ1OT1,NEK7,NFKB1,PRKACB,TRAF3	
NGF-stimulated transcription	5.7E-01	7.69E-02	NaN	ATF2,CHD4,TCF12	
Hypoxia Signaling in the Cardiovascular System	5.6E-01	6.58E-02	NaN	ARNT,ATF2,BIRC6,CREBBP,UBE2H	
Antioxidant Action of Vitamin C	5.59E-01	6.14E-02	-2.449	JAK2,MAPK8,NFKB1,NXN,PLCB1,PLCB4,PLCG1	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	5.59E-01	6.14E-02	1.890	ATF2,BCL2,BRAF,MAP2K6,MAPK8,NFKB1,RPS6KA3	
Aryl hydrocarbon receptor signalling	5.49E-01	1.43E-01	NaN	ARNT	
TYSND1 cleaves peroxisomal proteins	5.49E-01	1.43E-01	NaN	AGPS	
STAT5 Activation	5.49E-01	1.43E-01	NaN	GAB2	
Atorvastatin ADME	5.49E-01	1.43E-01	NaN	SLCO2B1	
Thioredoxin Pathway	5.49E-01	1.43E-01	NaN	NXN	
Ceramide Degradation	5.49E-01	1.43E-01	NaN	ACER2	
Glycogen Biosynthesis II (from UDP-D-Glucose)	5.49E-01	1.43E-01	NaN	GBE1	
TREM1 Signaling	5.46E-01	6.49E-02	2.236	AKT3,JAK2,NFKB1,PLCG1,STAT3	
RAF-independent MAPK1/3 activation	5.4E-01	8.7E-02	NaN	JAK1,JAK2	
Apelin Cardiac Fibroblast Signaling Pathway	5.4E-01	8.7E-02	NaN	AKT3,TGFB2	
Transport of vitamins, nucleosides, and related molecules	5.31E-01	7.32E-02	NaN	SLC16A2,SLCO1C1,SLCO2B1	
Retinoic acid Mediated Apoptosis Signaling	5.21E-01	6.67E-02	1.000	CFLAR,PARP14,TNKS,TNKS2	
Methionine Degradation I (to Homocysteine)	5.15E-01	8.33E-02	NaN	AHCYL2,EHMT1	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	5.12E-01	7.14E-02	NaN	MAP3K1,PELI1,TAB2	
Glycerophospholipid biosynthesis	5.1E-01	6.06E-02	2.449	CHKA,ETNK1,LCLAT1,LPIN2,OSBPL8,SLC44A1	
Dopamine Receptor Signaling	5.07E-01	6.25E-02	NaN	ADCY9,PPM1L,PPP1R12A,PPP2R5E,PRKACB	
TRAIL signaling	5.01E-01	1.25E-01	NaN	CFLAR	
NFE2L2 regulates pentose phosphate pathway genes	5.01E-01	1.25E-01	NaN	CREBBP	
Sphingomyelin Metabolism	5.01E-01	1.25E-01	NaN	SGMS1	
Assembly and cell surface presentation of NMDA receptors	4.95E-01	6.98E-02	NaN	CASK,DLG1,NBEA	
Peroxisomal protein import	4.77E-01	6.35E-02	2.000	AGPS,IDE,LONP2,USP9X	
Regulation of mRNA stability by proteins that bind AU-rich elements	4.77E-01	6.82E-02	NaN	EIF4G1,TNPO1,XRN1	
TBC/RABGAPs	4.77E-01	6.82E-02	NaN	RABGAP1,TBC1D14,TBC1D16	
COPI-mediated anterograde transport	4.77E-01	5.88E-02	2.449	COG5,DYNC1H1,GBF1,GOLGB1,SPTAN1,SPTBN1	
Transport of bile salts and organic acids, metal ions and amine compounds	4.7E-01	6.02E-02	2.236	CP,SLC16A1,SLC30A1,SLC39A10,SLC44A1	
IL-17A Signaling in Gastric Cells	4.68E-01	7.69E-02	NaN	MAPK8,NFKB1	
Estrogen-mediated S-phase Entry	4.68E-01	7.69E-02	NaN	CCND1,RB1	
Cysteine Biosynthesis III (mammalia)	4.68E-01	7.69E-02	NaN	AHCYL2,EHMT1	
Carboxyterminal post-translational modifications of tubulin	4.61E-01	6.67E-02	NaN	AGTPBP1,TTLL5,TTLL7	
Abacavir ADME	4.6E-01	1.11E-01	NaN	ABCB1	
Interleukin-1 processing	4.6E-01	1.11E-01	NaN	NFKB1	
Butyrophilin (BTN) family interactions	4.6E-01	1.11E-01	NaN	XDH	
Prednisone ADME	4.6E-01	1.11E-01	NaN	ABCB1	
Sphingosine and Sphingosine-1-phosphate Metabolism	4.6E-01	1.11E-01	NaN	ACER2	
Folate Transformations I	4.6E-01	1.11E-01	NaN	MTR	
Role of MAPK Signaling in the Pathogenesis of Influenza	4.58E-01	5.95E-02	NaN	AKT3,ATF2,BCL2,MAP2K6,MAPK8	
Fatty acyl-CoA biosynthesis	4.47E-01	7.41E-02	NaN	ACACA,ACSL3	
SUMOylation of RNA binding proteins	4.45E-01	6.52E-02	NaN	HNRNPC,PHC3,SCMH1	
Degradation of the extracellular matrix	4.38E-01	6.06E-02	2.000	ADAMTS9,HSPG2,LAMC1,NID1	
ATF6 (ATF6-alpha) activates chaperone genes	4.23E-01	1E-01	NaN	ATF6	
Ketone body metabolism	4.23E-01	1E-01	NaN	HMGCS2	
RHOBTB3 ATPase cycle	4.23E-01	1E-01	NaN	CUL3	
Citrulline Biosynthesis	4.23E-01	1E-01	NaN	GLS	
nNOS Signaling in Skeletal Muscle Cells	4.15E-01	6.25E-02	NaN	CACNA1E,ITPR1,ITPR2	
Apelin Muscle Signaling Pathway	4.15E-01	6.25E-02	NaN	AKT3,GNAQ,NRF1	
Energy dependent regulation of mTOR by LKB1-AMPK	4.08E-01	6.9E-02	NaN	CAB39,RPTOR	
mRNA Capping	4.08E-01	6.9E-02	NaN	MNAT1,RNGTT	
Sensory processing of sound by inner hair cells of the cochlea	4.02E-01	5.8E-02	2.000	CASK,MYH9,SPTAN1,SPTBN1	
Agrin Interactions at Neuromuscular Junction	4.02E-01	5.8E-02	NaN	LAMC1,MAPK8,PTK2,UTRN	
Nonhomologous End-Joining (NHEJ)	4.01E-01	6.12E-02	NaN	BABAM2,HERC2,PRKDC	
B Cell Receptor Signaling	3.97E-01	4.89E-02	4.382	ABL1,AKT3,ATF2,BCL2L1,CREBBP,EBF1,ETS1,FOXO1,GAB1,GAB2,INPP5F,MALT1,MAP2K6,MAP3K1,MAP3K2,MAP3K3,MAPK8,MEF2C,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCB,PTK2,RPS6KB1,SOS1,SOS2	
Regulation of Cellular Mechanics by Calpain Protease	3.94E-01	5.56E-02	NaN	CCND1,ITGA1,ITGA6,PTK2,RB1	
Neurotransmitter receptors and postsynaptic signal transmission	3.91E-01	9.09E-02	NaN	NBEA	
Pexophagy	3.91E-01	9.09E-02	NaN	EPAS1	
Ketogenesis	3.91E-01	9.09E-02	NaN	HMGCS2	
Glycogen Degradation II	3.91E-01	9.09E-02	NaN	PGM5	
GDP-glucose Biosynthesis	3.91E-01	9.09E-02	NaN	PGM5	
Activation of kainate receptors upon glutamate binding	3.9E-01	6.67E-02	NaN	DLG1,PLCB1	
Mitophagy	3.9E-01	6.67E-02	NaN	MFN1,PRKN	
RNA Polymerase I Transcription	3.88E-01	6E-02	NaN	CHD4,KAT2B,MNAT1	
Toll-like Receptor Cascades	3.73E-01	6.45E-02	NaN	DNM3,PTPN4	
Bile acid and bile salt metabolism	3.73E-01	6.45E-02	NaN	NCOA1,NCOA2	
Asparagine N-linked glycosylation	3.73E-01	6.45E-02	NaN	CANX,FUT8	
Sonic Hedgehog Signaling	3.73E-01	6.45E-02	NaN	DYRK1A,PRKACB	
COPII-mediated vesicle transport	3.68E-01	5.56E-02	2.000	ANKRD28,ANKRD44,PPP6R3,TRAPPC9	
Presynaptic depolarization and calcium channel opening	3.63E-01	8.33E-02	NaN	CACNA1E	
GP1b-IX-V activation signalling	3.63E-01	8.33E-02	NaN	PIK3R1	
Hematopoiesis from Multipotent Stem Cells	3.63E-01	8.33E-02	NaN	KITLG	
Glucose and Glucose-1-phosphate Degradation	3.63E-01	8.33E-02	NaN	PGM5	
Telomere Maintenance	3.58E-01	5.48E-02	2.000	ANKRD28,ATRX,PPP6R3,WRN	
Regulation of RUNX2 expression and activity	3.58E-01	5.48E-02	2.000	FBXW7,HIVEP3,PSME4,SMURF1	
Toll Like Receptor 3 (TLR3) Cascade	3.57E-01	6.25E-02	NaN	TAB2,TRAF3	
G-protein beta:gamma signalling	3.57E-01	6.25E-02	NaN	AKT3,PLCB1	
Interferon gamma signaling	3.56E-01	5.32E-02	2.236	JAK1,JAK2,MID1,PIAS1,TRIM25	
Cellular response to hypoxia	3.38E-01	5.33E-02	2.000	ARNT,CREBBP,EPAS1,PSME4	
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	3.37E-01	7.69E-02	NaN	STAT3	
Advanced glycosylation endproduct receptor signaling	3.37E-01	7.69E-02	NaN	APP	
Mitochondrial calcium ion transport	3.37E-01	7.69E-02	NaN	MCU	
Processing of SMDT1	3.37E-01	7.69E-02	NaN	MCU	
Glycogen Degradation III	3.37E-01	7.69E-02	NaN	PGM5	
Guanosine Nucleotides Degradation III	3.37E-01	7.69E-02	NaN	XDH	
Triglyceride metabolism	3.27E-01	5.88E-02	NaN	LPIN2,PRKACB	
Amino acids regulate mTORC1	3.27E-01	5.45E-02	NaN	DEPDC5,FNIP1,RPTOR	
Ion channel transport	3.24E-01	4.92E-02	3.000	ANO6,ATP10A,ATP11C,ATP1A2,ATP8A1,ATP9B,NEDD4L,TRPM7,WNK1	
Sirtuin Signaling Pathway	3.2E-01	4.81E-02	1.941	APP,ATG10,CLOCK,EPAS1,FOXO1,FOXO3,GLS,HMGCS2,NFKB1,PRKDC,RPTOR,SP1,STAT3,WRN	
Glutamate and glutamine metabolism	3.14E-01	7.14E-02	NaN	GLS	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	3.14E-01	7.14E-02	NaN	XDH	
Mevalonate Pathway I	3.14E-01	7.14E-02	NaN	HMGCS2	
Colanic Acid Building Blocks Biosynthesis	3.14E-01	7.14E-02	NaN	GMDS	
Oxytocin in Spinal Neurons Signaling Pathway	3.13E-01	5.71E-02	NaN	PRKG1,SMARCC2	
PRC2 methylates histones and DNA	3.13E-01	5.71E-02	NaN	DNMT3A,JARID2	
Cell Cycle Checkpoints	3.08E-01	4.78E-02	3.606	BABAM2,CLASP1,CLASP2,CLIP1,COP1,DYNC1H1,HERC2,MAD1L1,PHF20,PPP2R5E,PSME4,TAOK1,WRN	
Maturity Onset Diabetes of Young (MODY) Signaling	3.01E-01	5.06E-02	NaN	CACNA1E,CREBBP,INSR,NFKB1	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	3E-01	5.56E-02	NaN	CREBBP,WWOX	
Role of CHK Proteins in Cell Cycle Checkpoint Control	2.96E-01	5.17E-02	NaN	PPM1L,PPP2R5E,TLK2	
Platelet Adhesion to exposed collagen	2.94E-01	6.67E-02	NaN	ITGA1	
Fatty Acid Activation	2.94E-01	6.67E-02	NaN	ACSL3	
Choline Biosynthesis III	2.94E-01	6.67E-02	NaN	PHKA1	
Glycosaminoglycan metabolism	2.93E-01	5E-02	2.000	CSGALNACT1,EXT1,HSPG2,ST3GAL3	
NOD1/2 Signaling Pathway	2.9E-01	4.76E-02	1.667	ERBIN,MAP2K6,MAP4K4,MAPK8,NFKB1,TAB2,TGFB2,TRAF3,XIAP	
Cell surface interactions at the vascular wall	2.89E-01	4.74E-02	3.162	GLG1,GRB14,ITGA6,MERTK,PECAM1,PIK3CA,PIK3R1,PLCG1,SLC16A1,SOS1	
MyD88-independent TLR4 cascade	2.88E-01	5.41E-02	NaN	TAB2,TRAF3	
Mitotic Prophase	2.83E-01	4.85E-02	2.236	LPIN2,NEK7,NUMA1,PRKCB,RB1	
NIK-->noncanonical NF-kB signaling	2.76E-01	5E-02	NaN	BTRC,FBXW11,PSME4	
Caspase activation via Death Receptors in the presence of ligand	2.75E-01	6.25E-02	NaN	CFLAR	
Signal regulatory protein family interactions	2.75E-01	6.25E-02	NaN	PTK2	
Chondroitin Sulfate Degradation (Metazoa)	2.75E-01	6.25E-02	NaN	ARSB	
Superpathway of Citrulline Metabolism	2.75E-01	6.25E-02	NaN	GLS	
Bile Acid Biosynthesis, Neutral Pathway	2.75E-01	6.25E-02	NaN	Akr1c14	
Adenosine Nucleotides Degradation II	2.75E-01	6.25E-02	NaN	XDH	
RNA polymerase II transcribes snRNA genes	2.68E-01	4.82E-02	2.000	INTS9,POU2F1,SNAPC3,SP1	
Kinesins	2.67E-01	4.92E-02	NaN	KIF13B,KIF16B,KIF1B	
Inhibition of Matrix Metalloproteases	2.64E-01	5.13E-02	NaN	HSPG2,RECK	
RAN Signaling	2.57E-01	5.88E-02	NaN	TNPO1	
Post-translational protein phosphorylation	2.56E-01	4.67E-02	2.236	APP,CP,IGFBP7,LAMC1,MIA3	
BAG2 Signaling Pathway	2.53E-01	4.71E-02	0.000	NFKB1,PRKN,PSME4,SP1	
Metabolism of Angiotensinogen to Angiotensins	2.41E-01	5.56E-02	NaN	AOPEP	
Unfolded Protein Response (UPR)	2.41E-01	5.56E-02	NaN	ATF6	
Branched-chain amino acid catabolism	2.41E-01	5.56E-02	NaN	PPM1K	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	2.41E-01	5.56E-02	NaN	HMGCS2	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	2.33E-01	4.76E-02	NaN	CSGALNACT1,LARGE1	
Metabolism of cofactors	2.27E-01	5.26E-02	NaN	PDSS2	
NFE2L2 regulating anti-oxidant/detoxification enzymes	2.27E-01	5.26E-02	NaN	CREBBP	
Î³-linolenate Biosynthesis II (Animals)	2.27E-01	5.26E-02	NaN	ACSL3	
Purine Nucleotides Degradation II (Aerobic)	2.27E-01	5.26E-02	NaN	XDH	
Mitochondrial L-carnitine Shuttle Pathway	2.27E-01	5.26E-02	NaN	ACSL3	
Vasopressin regulates renal water homeostasis via Aquaporins	2.24E-01	4.65E-02	NaN	ADCY9,PRKACB	
Aggrephagy	2.24E-01	4.65E-02	NaN	DYNC1H1,PRKN	
SUMOylation of transcription factors	2.13E-01	5E-02	NaN	PIAS1	
Receptor-type tyrosine-protein phosphatases	2.13E-01	5E-02	NaN	PPFIBP1	
Synaptic adhesion-like molecules	2E-01	4.76E-02	NaN	DLG1	
Immunogenic Cell Death Signaling Pathway	-0E00	4.44E-02	1.000	BCL2,CFLAR,NFKB1,ROCK1	
Macrophage Classical Activation Signaling Pathway	-0E00	4.23E-02	0.378	JAK1,JAK2,JARID2,MERTK,NFKB1,PARP14,STAT3,TGFB2	
Multiple Sclerosis Signaling Pathway	-0E00	3.6E-02	2.828	BRAF,JARID2,NFKB1,PARP14,RNF213,TGFB2,TNKS,TNKS2	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	2.96E-02	2.111	AP3B1,COL4A2,CXCL12,IFIH1,JAK1,JAK2,LYST,MAPK8,NFKB1,STAT3,TGFB2	
Chaperone Mediated Autophagy Signaling Pathway	-0E00	2.99E-02	-2.524	APP,CCND1,CREBBP,DDX3X,HTT,IGF1R,KAT2B,LRRK2,MEF2A,NCOR1,NFKB1,PHLPP1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,RICTOR	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	4.32E-02	-1.633	ADCY9,CACNA1E,GLS,ITPR1,ITPR2,PRKACB	
Microautophagy Signaling Pathway	-0E00	1.87E-02	NaN	COL4A2,PSME4,RETREG1	
NFKBIE Signaling Pathway	-0E00	1.34E-02	0.000	ANKRD28,ANKRD44,DYSF,MAP3K3,NFKB1,PPP6R3	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	3.11E-02	0.000	ABCB1,ABCC4,ACSL3,CHST11,HMGCS2,MAP3K1,MAPK8,NCOA1	
G alpha (i) signalling events	-0E00	1.55E-02	2.000	ADCY9,APP,CXCL12,RGS5	
Potassium Channels	-0E00	9.71E-03	NaN	KCNQ1	
The citric acid (TCA) cycle and respiratory electron transport	-0E00	1.82E-02	NaN	SLC16A1	
Collagen degradation	-0E00	1.64E-02	NaN	COL4A2	
Phase II - Conjugation of compounds	-0E00	1.49E-02	NaN	MTR	
Elastic fibre formation	-0E00	4.55E-02	NaN	TGFB2,VTN	
Sulfur amino acid metabolism	-0E00	4.17E-02	NaN	MTR	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	-0E00	7.81E-03	NaN	CYB5B	
Gamma carboxylation, hypusine formation and arylsulfatase activation	-0E00	2.44E-02	NaN	ARSB	
Collagen biosynthesis and modifying enzymes	-0E00	2.99E-02	NaN	COL4A2,COLGALT2	
Complement cascade	-0E00	1.48E-02	NaN	CD46,VTN	
Regulation of Apoptosis	-0E00	1.89E-02	NaN	PSME4	
Plasma lipoprotein assembly, remodeling, and clearance	-0E00	2.63E-02	NaN	LIPA,PRKACB	
Metabolism of porphyrins	-0E00	4.35E-02	NaN	SLCO2B1	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	4.95E-03	NaN	MICB	
Assembly of collagen fibrils and other multimeric structures	-0E00	3.28E-02	NaN	COL4A2,ITGA6	
Generic Transcription Pathway	-0E00	4.44E-02	4.359	CREBBP,HDAC4,HDAC7,HDAC8,HDAC9,KAT2B,MAML3,MED13,MED14,NCOR1,NOTCH1,NR1D1,NR2C2,NR3C2,RORA,TBL1X,TBL1XR1,ZNF274,ZNF704	
Gene Silencing by RNA	-0E00	4.21E-02	2.000	AGO3,DICER1,TNRC6A,TNRC6B	
Phase I - Functionalization of compounds	-0E00	3.92E-02	2.000	ARNT,CYB5B,NCOA1,NCOA2	
MHC class II antigen presentation	-0E00	3.17E-02	2.000	AP1G1,CANX,DNM3,DYNC1H1	
Binding and Uptake of Ligands by Scavenger Receptors	-0E00	8.93E-03	NaN	COL4A2	
DNA Damage/Telomere Stress Induced Senescence	-0E00	3.57E-02	NaN	EP400,RB1	
SUMOylation of ubiquitinylation proteins	-0E00	2.63E-02	NaN	PIAS1	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	-0E00	3.64E-02	NaN	DYNC1H1,NR3C2	
Cellular response to heat stress	-0E00	2.06E-02	NaN	CREBBP,RPTOR	
Metabolism of polyamines	-0E00	1.69E-02	NaN	PSME4	
Class A/1 (Rhodopsin-like receptors)	-0E00	9.46E-03	NaN	APP,CXCL12,ECE1	
Class B/2 (Secretin family receptors)	-0E00	2.08E-02	NaN	CALCRL,FZD6	
ATF4 activates genes in response to endoplasmic reticulum stress	-0E00	3.7E-02	NaN	ATF6	
XBP1(S) activates chaperone genes	-0E00	2.08E-02	NaN	EXTL3	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	-0E00	4.03E-02	2.236	APP,CP,IGFBP7,LAMC1,MIA3	
ABC-family proteins mediated transport	-0E00	2.97E-02	NaN	ABCB1,ABCC4,PSME4	
Protein folding	-0E00	4.08E-02	2.000	FBXW7,GNAQ,LONP2,STAT3	
Signal amplification	-0E00	3.03E-02	NaN	GNAQ	
Incretin synthesis, secretion, and inactivation	-0E00	4E-02	NaN	TCF7L2	
G alpha (s) signalling events	-0E00	4.14E-02	2.449	ADCY9,CALCRL,GRK5,PDE10A,PDE7B,PDE8A	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	3.85E-02	2.000	AHCYL2,SLC12A6,SLC1A1,SLC7A1	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	-0E00	2.7E-02	NaN	CHD4	
NoRC negatively regulates rRNA expression	-0E00	2.63E-02	NaN	SAP130	
Activation of NMDA receptors and postsynaptic events	-0E00	3.57E-02	NaN	DLG1,PRKACB,RPS6KA3	
Other interleukin signaling	-0E00	4.17E-02	NaN	JAK1	
Regulation of mitotic cell cycle	-0E00	4.55E-02	2.000	BTRC,CDC14A,PSME4,RB1	
Thrombin signalling through proteinase activated receptors (PARs)	-0E00	3.12E-02	NaN	GNAQ	
SUMOylation of DNA replication proteins	-0E00	2.22E-02	NaN	TOP2B	
B-WICH complex positively regulates rRNA expression	-0E00	3.85E-02	NaN	BAZ1B,KAT2B	
DNA methylation	-0E00	3.85E-02	NaN	DNMT3A	
Hedgehog ligand biogenesis	-0E00	1.54E-02	NaN	PSME4	
Hedgehog 'off' state	-0E00	4.42E-02	2.236	ADCY9,BTRC,NUMB,PRKACB,PSME4	
RHO GTPases activate IQGAPs	-0E00	3.23E-02	NaN	CLIP1	
TP53 Regulates Transcription of Cell Death Genes	-0E00	2.27E-02	NaN	CREBBP	
TNFR2 non-canonical NF-kB pathway	-0E00	2.94E-02	NaN	PSME4,TRAF3	
RHO GTPases Activate NADPH Oxidases	-0E00	4.55E-02	NaN	PRKCB	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	-0E00	4.46E-02	2.236	ABL1,BABAM2,HERC2,SPIDR,WRN	
Cargo concentration in the ER	-0E00	2.94E-02	NaN	MIA3	
Nucleotide Excision Repair	-0E00	3.09E-02	NaN	MNAT1,PIAS1,USP7	
Fanconi Anemia Pathway	-0E00	2.63E-02	NaN	FANCC	
Interleukin-10 signaling	-0E00	4.44E-02	NaN	JAK1,STAT3	
Major pathway of rRNA processing in the nucleolus and cytosol	-0E00	5.38E-03	NaN	UTP14C	
Neutrophil degranulation	-0E00	3.78E-02	4.243	ANO6,ARMC8,ARSB,ATP8A1,CAB39,CDK13,DDX3X,DNAJC13,DYNC1H1,HUWE1,NFKB1,PECAM1,PTPRB,RAB31,ROCK1,SCAMP1,SPTAN1,UBR4	
Regulation of TP53 Activity through Phosphorylation	-0E00	4.3E-02	2.000	HIPK1,HIPK2,TAF3,WRN	
Keratinization	-0E00	4.67E-03	NaN	PKP4	
Synthesis of DNA	-0E00	8.4E-03	NaN	PSME4	
Glucose metabolism	-0E00	1.25E-02	NaN	PRKACB	
Processing of Capped Intron-Containing Pre-mRNA	-0E00	3.48E-02	3.162	CPSF6,CSTF3,CWC27,DDX46,HNRNPC,LUC7L3,PAPOLA,SNRNP200,THOC2,WDR33	
Eukaryotic Translation Initiation	-0E00	1.64E-02	NaN	CP,EIF4G1	
DNA Damage Bypass	-0E00	2.08E-02	NaN	TRIM25	
Response to elevated platelet cytosolic Ca2+	-0E00	4.55E-02	2.449	ABCC4,APP,PECAM1,PHACTR2,PRKCB,TGFB2	
Mitochondrial Fatty Acid Beta-Oxidation	-0E00	4.17E-02	NaN	PCCA	
Nucleosome assembly	-0E00	2.04E-02	NaN	RSF1	
E3 ubiquitin ligases ubiquitinate target proteins	-0E00	3.64E-02	NaN	PRKDC,SHPRH	
RAB geranylgeranylation	-0E00	1.54E-02	NaN	RAB31	
Collagen chain trimerization	-0E00	2.27E-02	NaN	COL4A2	
Nucleotide catabolism	-0E00	3.33E-02	NaN	XDH	
Interferon alpha/beta signaling	-0E00	1.41E-02	NaN	JAK1	
Iron uptake and transport	-0E00	1.72E-02	NaN	CP	
Nonsense-Mediated Decay (NMD)	-0E00	3.42E-02	2.000	EIF4G1,SMG1,SMG6,SMG7	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	-0E00	4.55E-02	NaN	APP	
Response of EIF2AK4 (GCN2) to amino acid deficiency	-0E00	1.94E-02	NaN	ATF2,EIF2AK4	
GPER1 signaling	-0E00	4.44E-02	NaN	ADCY9,PRKACB	
RAS processing	-0E00	4.17E-02	NaN	BCL2L1	
Expression and translocation of olfactory receptors	-0E00	2.51E-03	NaN	EBF1	
Retinoid metabolism and transport	-0E00	4.55E-02	NaN	HSPG2,LRP8	
GABA receptor activation	-0E00	1.67E-02	NaN	ADCY9	
LXR/RXR Activation	-0E00	3.25E-02	NaN	ACACA,NCOR1,NFKB1,VTN	
CGAS-STING Signaling Pathway	-0E00	2.14E-02	NaN	GJA1,NFKB1,TGFB2	
FXR/RXR Activation	-0E00	3.21E-02	-0.816	AKT3,CREBBP,FOXO1,MAPK8,NFKB1,TGFB2	
BBSome Signaling Pathway	-0E00	3.48E-02	4.000	ADGRF5,ADGRL3,ADGRL4,ASXL2,ATF6,BBS9,CALCRL,CUL3,CXCL12,FZD6,GPR155,IGF1R,INSR,LEPR,PCM1,PRKACB,STAT3	
MIF Regulation of Innate Immunity	-0E00	4.55E-02	NaN	MAPK8,NFKB1	
Role of NFAT in Regulation of the Immune Response	-0E00	2.22E-02	4.025	AKT3,ATF2,CSNK1G1,GNAQ,ITPR1,ITPR2,MEF2A,MEF2C,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,RCAN2,SOS1,SOS2,TNPO1	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	1.69E-02	2.449	CACNA1E,ITPR1,ITPR2,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1	
CCR5 Signaling in Macrophages	-0E00	2.2E-02	2.646	CACNA1E,GNAQ,ITPR1,ITPR2,MAPK8,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Calcium-induced T Lymphocyte Apoptosis	-0E00	2.17E-02	3.162	ITPR1,ITPR2,PLCG1,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	2.35E-03	NaN	BCL2	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	1.69E-02	NaN	FGF13,TGFB2	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	2.63E-02	-1.500	AKT3,AP1G1,BCL2L1,CBLB,MALT1,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP2R5E,TGFB2	
Airway Inflammation in Asthma	-0E00	3.03E-02	NaN	TGFB2	
T Helper Cell Differentiation	-0E00	4.25E-03	NaN	STAT3,TGFBR2	
CD28 Signaling in T Helper Cells	-0E00	2.9E-02	3.873	AKT3,ITPR1,ITPR2,MALT1,MAP3K1,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC	
IL-15 Signaling	-0E00	2.28E-02	3.464	AKT3,BCL2L1,JAK1,JAK2,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RPS6KB1,RPTOR,STAT3	
Dendritic Cell Maturation	-0E00	2.35E-02	3.742	AKT3,ATF2,CREBBP,JAK2,LEPR,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	2.56E-02	3.317	AKT3,GAB2,ITPR1,ITPR2,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC	
Lipid Antigen Presentation by CD1	-0E00	2.41E-03	NaN	CANX	
Type I Diabetes Mellitus Signaling	-0E00	1.77E-02	0.707	BCL2,ICA1,JAK1,JAK2,MAP2K6,MAPK8,NFKB1,PIAS1,SOCS7	
p70S6K Signaling	-0E00	3.45E-02	3.900	AKT3,GNAQ,JAK1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCB1,PLCB4,PLCG1,PPM1L,PPP2R5E,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KB1,SOS1,SOS2	
G Protein Signaling Mediated by Tubby	-0E00	1.71E-02	2.828	ABL1,GNAQ,INSR,JAK2,MERTK,PLCB1,PLCB4,PLCG1	
Crosstalk between Dendritic Cells and Natural Killer Cells	-0E00	2.2E-02	NaN	MICB,NFKB1	
Systemic Lupus Erythematosus Signaling	-0E00	1.22E-02	NaN	AKT3,CBL,HNRNPC,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRPF39,SNRNP200,SOS1,SOS2	
CDC42 Signaling	-0E00	2.95E-02	0.632	APC,ATF2,CDC42BPA,CLIP1,EXOC2,EXOC4,EXOC6,EXOC6B,ITGA1,ITGA6,MAPK8,MPRIP,PARD3,PPP1R12A,Ppp1r12b,TNK2,WIPF1	
FAK Signaling	-0E00	4.61E-02	6.351	ACVR2A,ADGRF5,ADGRL3,ADGRL4,AKT3,APC,ASAP1,BCAR3,BMPR2,CALCRL,CCND1,CRKL,DOCK1,ELF2,ETS1,FLT1,FLT4,FZD6,GHR,GIT2,GPR155,IGF1R,ITGA1,ITGA6,KDR,LEF1,MAP2K5,MAPK8,NEDD9,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PTK2,PTPRA,RB1CC1,SOCS7,SOS1,SOS2,SP1,TCF4,TCF7L2,TGFB2,TGFBR2,TGFBR3,WIPF1	
Phospholipase C Signaling	-0E00	3.39E-02	4.596	ADCY9,AHNAK,ARHGEF11,ARHGEF12,ARHGEF3,ATF2,CREBBP,GNAQ,HDAC4,HDAC7,HDAC8,HDAC9,ITGA1,ITGA6,ITPR1,ITPR2,MEF2A,MEF2C,MPRIP,NFAT5,NFKB1,PLCB1,PLCB4,PLCG1,PPP1R12A,Ppp1r12b,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RHOBTB1,RHOJ,RPS6KA3,SOS1,SOS2	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	2.13E-03	NaN	NFKB1,TRAF3	
Atherosclerosis Signaling	-0E00	3.01E-02	NaN	CXCL12,GLG1,NFKB1,PDGFD	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00	3.28E-02	NaN	APP,ECE1,IDE,PRKACB	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	2.81E-02	1.941	MALT1,MAP3K1,MAPK8,NFAT5,NFKB1,PLCG1,PPP3CA,PPP3CC,SMAD3,SOS1,SOS2,TGFB2,TGFBR2	
NUR77 Signaling in T Lymphocytes	-0E00	2.73E-02	2.138	BCL2,HDAC7,HDAC9,MAP2K5,MAP3K2,MAP3K3,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RPS6KA3	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	3.58E-02	4.000	CACNA1E,ITPR1,ITPR2,MALT1,MAP3K1,MAP3K2,MAP3K3,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,POU2F1,PPP3CA,PPP3CC,SOS1,SOS2	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	-0E00	2.33E-02	NaN	JAK1,NFKB1	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	9.39E-03	2.000	RB1,SMAD3,TGFB2,TGFBR2	
OX40 Signaling Pathway	-0E00	1.05E-02	2.236	BCL2,BCL2L1,MAPK8,NFKB1,TRAF3	
PI3K Signaling in B Lymphocytes	-0E00	3.4E-02	3.900	ABL1,AKT3,ATF2,ATF6,ATF7,CBL,FOXO3,ITPR1,ITPR2,MALT1,NFAT5,NFKB1,PIK3CA,PIK3R1,PLCB1,PLCB4,PLCG1,PPP3CA,PPP3CC,PRKCB	
MIF-mediated Glucocorticoid Regulation	-0E00	2.78E-02	NaN	NFKB1	
Assembly of RNA Polymerase II Complex	-0E00	4E-02	NaN	MNAT1,TAF3	
Spliceosomal Cycle	-0E00	3.77E-02	NaN	DDX46,SNRNP200	
Hematopoiesis from Pluripotent Stem Cells	-0E00	2.24E-03	NaN	KITLG	
Heparan Sulfate Biosynthesis	-0E00	3.33E-02	NaN	CHST11,EXT1,EXTL3	
Retinoate Biosynthesis I	-0E00	2.33E-02	NaN	Akr1c14	
Nicotine Degradation III	-0E00	3.33E-02	NaN	CSGALNACT1,LARGE1	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	3.61E-02	NaN	CHST11,EXT1,EXTL3	
Pyrimidine Ribonucleotides De Novo Biosynthesis	-0E00	2.33E-02	NaN	DDX3X	
CDP-diacylglycerol Biosynthesis I	-0E00	3.57E-02	NaN	LCLAT1	
Melatonin Degradation I	-0E00	3.12E-02	NaN	CSGALNACT1,LARGE1	
Triacylglycerol Degradation	-0E00	1.72E-02	NaN	ABHD2	
Phospholipases	-0E00	4.35E-02	NaN	PLCB1,PLCB4,PLCG1	
Chondroitin Sulfate Biosynthesis	-0E00	3.28E-02	NaN	CHST11,CSGALNACT1	
Dermatan Sulfate Biosynthesis	-0E00	3.17E-02	NaN	CHST11,CSGALNACT1	
tRNA Charging	-0E00	2.56E-02	NaN	FARS2	
Dermatan Sulfate Biosynthesis (Late Stages)	-0E00	2E-02	NaN	CHST11	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	-0E00	3.33E-02	NaN	LCLAT1	
Nicotine Degradation II	-0E00	2.94E-02	NaN	CSGALNACT1,LARGE1	
Serotonin Degradation	-0E00	2.74E-02	NaN	CSGALNACT1,LARGE1	
Triacylglycerol Biosynthesis	-0E00	3.57E-02	NaN	LCLAT1,LPIN2	
Pyrimidine Ribonucleotides Interconversion	-0E00	2.5E-02	NaN	DDX3X	
Methylglyoxal Degradation III	-0E00	3.23E-02	NaN	Akr1c14	
Chondroitin Sulfate Biosynthesis (Late Stages)	-0E00	3.77E-02	NaN	CHST11,CSGALNACT1	
Superpathway of Melatonin Degradation	-0E00	2.9E-02	NaN	CSGALNACT1,LARGE1	
Stearate Biosynthesis I (Animals)	-0E00	1.41E-02	NaN	ACSL3	
Fatty Acid Î²-oxidation I	-0E00	2.94E-02	NaN	ACSL3	
Superpathway of Cholesterol Biosynthesis	-0E00	3.45E-02	NaN	HMGCS2	
GÎ±i Signaling	-0E00	4.29E-02	0.447	ADCY9,GNAQ,PRKACB,SOS1,SOS2,STAT3	
Agranulocyte Adhesion and Diapedesis	-0E00	3.81E-02	NaN	CXCL12,GLG1,MYH10,MYH9,MYO10,MYO18A,PECAM1,Podxl	
Granulocyte Adhesion and Diapedesis	-0E00	1.59E-02	NaN	CXCL12,GLG1,PECAM1	
TEC Kinase Signaling	-0E00	3.63E-02	4.123	GNAQ,ITGA1,ITGA6,JAK1,JAK2,MAPK8,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,PTK2,RHOBTB1,RHOJ,STAT3	
Oxidative Phosphorylation	-0E00	8.93E-03	NaN	CYB5B	
Nucleotide Excision Repair Pathway	-0E00	2.86E-02	NaN	MNAT1	
SAPK/JNK Signaling	-0E00	3.39E-02	4.123	ATF2,CRKL,GAB1,MAP3K1,MAP3K2,MAP3K20,MAP3K3,MAP4K3,MAP4K4,MAP4K5,MAPK8,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,SOS1,SOS2	
GABA Receptor Signaling	-0E00	3.79E-02	NaN	ADCY9,CACNA1E,GNAQ,ITPR1,ITPR2	
IL-4 Signaling	-0E00	3.29E-02	4.359	AKT3,ATF2,BCL2L1,COL4A2,CREBBP,GAB1,JAK1,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,RICTOR,RPS6KB1,RPTOR,SOS1,SOS2,STAT3,TGFB2	
Antigen Presentation Pathway	-0E00	2.56E-02	NaN	CANX	
Phototransduction Pathway	-0E00	1.85E-02	NaN	PRKACB	
Glutamate Receptor Signaling	-0E00	3.03E-02	NaN	GLS,SLC1A1	
T Cell Receptor Signaling	-0E00	3.73E-02	3.962	AKT3,ATF2,CBL,FOXO3,LEF1,MALT1,MAP2K6,MAP3K1,MAPK8,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPP3CA,PPP3CC,RPTOR,SOS1,SOS2,TCF4,TCF7L2	
Gustation Pathway	-0E00	3.96E-02	2.828	ADCY9,CACNA1E,ITPR1,ITPR2,LIPA,LRRC8C,LRRC8D,PRKACB	
Phagosome Maturation	-0E00	2.44E-02	NaN	CANX,DYNC1H1,PIKFYVE,VTI1A	
Th17 Activation Pathway	-0E00	1.24E-02	2.449	JAK1,JAK2,NFAT5,NFKB1,RORA,STAT3	
SPINK1 Pancreatic Cancer Pathway	-0E00	3.33E-02	NaN	SMAD3,TGFBR2	
NER (Nucleotide Excision Repair, Enhanced Pathway)	-0E00	3.3E-02	NaN	MNAT1,TOP2B,USP7	
Apelin Liver Signaling Pathway	-0E00	3.7E-02	NaN	MAPK8	
Apelin Adipocyte Signaling Pathway	-0E00	3.3E-02	NaN	ADCY9,MAPK8,PRKACB	
FAT10 Signaling Pathway	-0E00	3.51E-02	NaN	HTT,PSME4	
T Cell Exhaustion Signaling Pathway	-0E00	3.7E-02	1.606	ACVR2A,AKT3,BMPR2,FOXO1,JAK1,JAK2,KDR,MAPK8,MGAT5,NFAT5,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP2R5E,SMAD3,STAT3,TGFBR2,TGFBR3	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	4.35E-02	2.502	AKT3,ATF2,CBL,CREBBP,ITPR1,LEPR,MAP2K5,MAP2K6,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PLCG1,PPM1L,PPP2R5E,PPP3CA,PPP3CC,PTK2,RHOBTB1,RHOJ,ROCK1,ROCK2,RPS6KB1,RPTOR,SOS1,SOS2,SP1,STAT3	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	4.56E-02	4.352	AKT3,BCL2,BCL2L1,CBL,CCND1,FOXO1,FOXO3,GAB1,IFIH1,INPP5F,JAK1,JAK2,MALT1,MAP4K4,NFAT5,NFKB1,PIK3C2A,PIK3CA,PIK3R1,PIK3R3,PPP3CA,PPP3CC,PRKCB,PRKCE,PRKCH,PRKD1,PRKD3,RASGRP3,SOS1,SOS2,STAT3,TGFB2,TRAF3	
Complement System	-0E00	2.7E-02	NaN	CD46	
